Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Italie And NotMichela Barichella

List of bibliographic references

Number of relevant bibliographic references: 317.
Ident.Authors (with country if any)Title
000016 D C Consonni [Italie] ; Straif [France] ; Symons [États-Unis] ; Tomenson [Royaume-Uni] ; Amelsvoort Van [Pays-Bas] ; Sleeuwenhoek [Royaume-Uni] ; Cherrie [Royaume-Uni] ; Bonetti [Italie] ; Colombo [Italie] ; Farrar [Royaume-Uni] ; Carugno [Italie] ; Bertazzi [Italie]284 Cancer risk among tetrafluoroethylene (TFE) synthesis and polymerisation workers
000027 Aristide Merola [Italie] ; Maurizio Zibetti [Italie] ; Carlo Alberto Artusi [Italie] ; Alice Marchisio [Italie] ; Valeria Ricchi [Italie] ; Laura Rizzi [Italie] ; Serena Angrisano [Italie] ; Nichy Arduino [Italie] ; Michele Lanotte [Italie] ; Mario Rizzone [Italie] ; Leonardo Lopiano [Italie]Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?
000034 Michele Poletti [Italie] ; Daniela Frosini [Italie] ; Cristina Pagni [Italie] ; Filippo Baldacci [Italie] ; Valentina Nicoletti [Italie] ; Gloria Tognoni [Italie] ; Claudio Lucetti [Italie] ; Paolo Del Dotto [Italie] ; Roberto Ceravolo [Italie] ; Ubaldo Bonuccelli [Italie]Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease
000039 Andreas R. Kupsch [Allemagne] ; Nin Bajaj [Royaume-Uni] ; Frederick Weiland [États-Unis] ; Antonio Tartaglione [Italie] ; Susanne Klutmann [Allemagne] ; Melanie Buitendyk [Canada] ; Paul Sherwin [États-Unis] ; Ann Tate [États-Unis] ; Igor D. Grachev [États-Unis]Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study
000048 Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko KrügerA multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants
000068 Jane A. Driver [États-Unis] ; Giancarlo Logroscino [Italie] ; Linda Lu [États-Unis] ; J Michael Gaziano [États-Unis] ; Tobias Kurth [France]Use of non-steroidal anti-inflammatory drugs and risk of Parkinson’s disease: nested case-control study
000072 Letterio Morgante [Italie] ; Carlo Colosimo [Italie] ; Angelo Antonini [Italie] ; Roberto Marconi [Italie] ; Giuseppe Meco [Italie] ; Massimo Pederzoli [Italie] ; Francesco E. Pontieri [Italie] ; Giulio Cicarelli [Italie] ; Giovanni Abbruzzese [Italie] ; Salvatore Zappulla [Italie] ; Silvia Ramat [Italie] ; Michela Manfredi [Italie] ; Edo Bottacchi [Italie] ; Michele Abrignani [Italie] ; Alfredo Berardelli [Italie] ; Autilia Cozzolino [Italie] ; Claudio Paradiso [Italie] ; Danilo De Gaspari [Italie] ; Francesca Morgante [Italie] ; Paolo Barone [Italie]Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression
000095 Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Wearing‐off scales in Parkinson's disease: Critique and recommendations
000098 Carmine Vitale [Italie] ; Vincenzo Marcelli [Italie] ; Teresa Furia [Italie] ; Gabriella Santangelo [Italie] ; Autilia Cozzolino [Italie] ; Katia Longo [Italie] ; Roberto Allocca [Italie] ; Marianna Amboni [Italie] ; Elio Marciano [Italie] ; Paolo Barone [Italie]Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion
000110 P. Barone [Italie]Treatment of depressive symptoms in Parkinson’s disease
000120 Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Alfonso Fasano [Italie] ; Andrea E. Cavanna [Royaume-Uni]The prevalence and clinical characteristics of punding in Parkinson's disease
000140 Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Ad Theeuwes [Pays-Bas] ; Fabrizio Stocchi [Italie] ; Joaquim J. Ferreira [Portugal] ; Serge Van De Witte [Pays-Bas] ; Juliana Bronzova [Pays-Bas]Temporal stability of the Unified Dyskinesia Rating Scale
000164 Claudia Trenkwalder [Allemagne] ; Bryan Kies [Afrique du Sud] ; Monika Rudzinska [Pologne] ; Jennifer Fine [Afrique du Sud] ; Janos Nikl [Hongrie] ; Krystyna Honczarenko [Pologne] ; Peter Dioszeghy [Hongrie] ; Dennis Hill [États-Unis] ; Tim Anderson [Nouvelle-Zélande] ; Vilho Myllyla [Finlande] ; Jan Kassubek [Allemagne] ; Malcolm Steiger [Royaume-Uni] ; Marco Zucconi [Italie] ; Eduardo Tolosa [Espagne] ; Werner Poewe [Autriche] ; Erwin Surmann [Allemagne] ; John Whitesides [États-Unis] ; Babak Boroojerdi [Allemagne] ; Kallol Ray Chaudhuri [Royaume-Uni] ; the RECOVER Study GroupRotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)
000169 Alessandra Nicoletti [Italie] ; Giuseppe Nicoletti [Italie] ; Gennarina Arabia [Italie] ; Grazia Annesi [Italie] ; Michele De Mari [Italie] ; Paolo Lamberti [Italie] ; Lucia Grasso [Italie] ; Roberto Marconi [Italie] ; Antonio Epifanio [Italie] ; Letterio Morgante [Italie] ; Autilia Cozzolino [Italie] ; Paolo Barone [Italie] ; Aldo Quattrone [Italie] ; Mario Zappia [Italie]Reproductive factors and Parkinson's disease: A multicenter case–control study
000171 S. Giaquinto [Italie] ; L. Bruti [Italie] ; V. Dall'Armi [Italie] ; E. Palma [Italie] ; C. Spiridigliozzi [Italie]Religious and spiritual beliefs in outpatients suffering from Parkinson Disease
000180 Maria Teresa Pellecchia [Italie] ; Paolo Barone [Italie] ; Caterina Vicidomini [Italie] ; Carmine Mollica [Italie] ; Elena Salvatore [Italie] ; Marta Ianniciello [Italie] ; Raffaele Liuzzi [Italie] ; Katia Longo [Italie] ; Marina Picillo [Italie] ; Giuseppe De Michele [Italie] ; Alessandro Filla [Italie] ; Arturo Brunetti [Italie] ; Marco Salvatore [Italie] ; Sabina Pappatà [Italie]Progression of striatal and extrastriatal degeneration in multiple system atrophy: A longitudinal diffusion‐weighted MR study
000196 Roberto Cilia [Canada, Italie] ; Sang Soo Cho [Canada] ; Thilo Van Eimeren [Canada] ; Giorgio Marotta [Italie] ; Chiara Siri [Italie] ; Ji Hyun Ko [Canada] ; Giovanna Pellecchia [Canada] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] ; Antonio P. Strafella [Canada]Pathological gambling in patients with Parkinson's disease is associated with fronto‐striatal disconnection: A path modeling analysis
000213 Fabrizio Stocchi [Italie] ; Luigi Giorgi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni]PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease
000214 Valentina Berti [Italie] ; Alberto Pupi [Italie] ; Lisa Mosconi [États-Unis]PET/CT in diagnosis of dementia
000230 Lucia Frau [Italie] ; Franco Borsini [Italie] ; Jadwiga Wardas [Pologne] ; Amit S. Khairnar [Italie] ; Nicoletta Schintu [Italie] ; Micaela Morelli [Italie]Neuroprotective and anti‐inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease
000239 Davide Chiasserini [Italie] ; Alessandro Tozzi [Italie] ; Antonio De Iure [Italie] ; Michela Tantucci [Italie] ; Federica Susta [Italie] ; Pier Luigi Orvietani [Italie] ; Keizo Koya [États-Unis] ; Luciano Binaglia [Italie] ; Paolo Calabresi [Italie]Mortalin inhibition in experimental Parkinson's disease
000243 Alfonso Fasano [Allemagne, Italie] ; Jan Herzog [Allemagne] ; Elena Seifert [Allemagne] ; Henning Stolze [Allemagne] ; Daniela Falk [Allemagne] ; René Reese [Allemagne] ; Jens Volkmann [Allemagne] ; Günther Deuschl [Allemagne]Modulation of gait coordination by subthalamic stimulation improves freezing of gait
000244 Tito Calì [Italie] ; Denis Ottolini [Italie] ; Marisa Brini [Italie]Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease
000262 Giulia Longoni [Italie] ; Federica Agosta [Italie] ; Vladimir S. Kosti [Serbie] ; Tanja Stojkovi [Serbie] ; Elisabetta Pagani [Italie] ; Tatjana Stoši Pin Al [Serbie] ; Massimo Filippi [Italie]MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy‐parkinsonism, and Parkinson's disease
000266 R. Ceravolo ; L. Brusa [Italie] ; S. Galati [Italie] ; D. Volterrani ; A. Peppe [Italie] ; G. Siciliano ; M. Pierantozzi [Italie] ; V. Moschella [Italie] ; U. Bonuccelli ; P. Stanzione [Italie] ; A. Stefani [Italie]Low frequency stimulation of the nucleus tegmenti pedunculopontini increases cortical metabolism in Parkinsonian patients
000273 E. Pascale [Italie] ; E. Passarelli [Italie] ; C. Purcaro [Italie] ; A. R. Vestri [Italie] ; A. Fakeri [Italie] ; R. Guglielmi [Italie] ; F. Passarelli [Italie] ; G. Meco [Italie]Lack of association between IL‐1β, TNF‐α, and IL‐10 gene polymorphisms and sporadic Parkinson’s disease in an Italian cohort
000287 Alexis Elbaz [France] ; Owen A. Ross [États-Unis] ; John P. A. Ioannidis [Grèce, États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Frédéric Moisan [France] ; Jan Aasly [Norvège] ; Grazia Annesi [Italie] ; Maria Bozi [Grèce] ; Laura Brighina [Italie] ; Marie-Christine Chartier-Harlin [France] ; Alain Destée [France] ; Carlo Ferrarese [Italie] ; Alessandro Ferraris [Italie] ; J. Mark Gibson [Irlande (pays)] ; Suzana Gispert [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Barbara Jasinska-Myga [Pologne] ; Christine Klein [Allemagne] ; Rejko Krüger [Allemagne] ; Jean-Charles Lambert [France] ; Katja Lohmann [Allemagne] ; Simone Van De Loo [Allemagne] ; Marie-Anne Loriot [France] ; Timothy Lynch [Irlande (pays)] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Christer Nilsson [Suède] ; Grzegorz Opala [Pologne] ; Andreas Puschmann [Suède] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Leonidas Stefanis [Grèce] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Carles Vilari O-Güell [États-Unis, Canada] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis, Canada]Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
000290 Angelo Antonini [Italie] ; Chiara Siri [Italie] ; Gabriella Santangelo [Italie] ; Roberto Cilia [Italie] ; Michele Poletti [Italie] ; Margherita Canesi [Italie] ; Alessandra Caporali [Italie] ; Francesca Mancini [Italie] ; Gianni Pezzoli [Italie] ; Roberto Ceravolo [Italie] ; Ubaldo Bonuccelli [Italie] ; Paolo Barone [Italie]Impulsivity and compulsivity in drug‐naïve patients with Parkinson's disease
000315 B. Borroni ; S. Goldwurm [Italie] ; C. Cerini ; M. Cosseddu ; N. Meucci [Italie] ; C. Mariani [Italie] ; G. Pezzoli [Italie] ; A. PadovaniFamilial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome
000316 Armando Perrotta [Italie] ; Giorgio Sandrini [Italie] ; Mariano Serrao [Italie] ; Simona Buscone [Italie] ; Cristina Tassorelli [Italie] ; Michele Tinazzi [Italie] ; Roberta Zangaglia [Italie] ; Claudio Pacchetti [Italie] ; Michelangelo Bartolo [Italie] ; Francesco Pierelli [Italie] ; Emilia Martignoni [Italie]Facilitated temporal summation of pain at spinal level in Parkinson's disease
000328 F. Stocchi [Italie] ; J. M. Rabey [Israël]Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease
000341 E. Mulin [France] ; E. Leone [France] ; K. Dujardin [France] ; M. Delliaux [France] ; A. Leentjens [Pays-Bas] ; F. Nobili [Italie] ; B. Dessi [Italie] ; O. Tible [France] ; L. Agüera-Ortiz [Espagne] ; R. S. Osorio [Espagne] ; J. Yessavage [États-Unis] ; D. Dachevsky [Argentine] ; F. Rj. Verhey [Pays-Bas] ; Alfonso J. Cruz Jentoft [Espagne] ; O. Blanc [France] ; P. M Llorca [France] ; P. H. Robert [France]Diagnostic criteria for apathy in clinical practice
000355 Aristide Merola [Italie] ; Maurizio Zibetti [Italie] ; Serena Angrisano [Italie] ; Laura Rizzi [Italie] ; Michele Lanotte [Italie] ; Leonardo Lopiano [Italie]Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease
000356 Carmine Vitale [Italie] ; Gabriella Santangelo [Italie] ; Luigi Trojano [Italie] ; Francesca Verde [Italie] ; Mariangela Rocco [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease
000361 Paolo Barone [Italie] ; Dag Aarsland [Norvège] ; David Burn [Royaume-Uni] ; Murat Emre [Turquie] ; Jaime Kulisevsky [Espagne] ; Daniel Weintraub [États-Unis]Cognitive impairment in nondemented Parkinson's disease
000373 Lucilla Parnetti [Italie] ; Davide Chiasserini [Italie] ; Gianni Bellomo [Italie] ; David Giannandrea [Italie] ; Claudia De Carlo [Italie] ; Mohamed M. Qureshi [Émirats arabes unis] ; Mustafa T. Ardah [Émirats arabes unis] ; Shiji Varghese [Émirats arabes unis] ; Laura Bonanni [Italie] ; Barbara Borroni [Italie] ; Nicola Tambasco [Italie] ; Paolo Eusebi [Italie] ; Aroldo Rossi [Italie] ; Marco Onofrj [Italie] ; Alessandro Padovani [Italie] ; Paolo Calabresi [Italie] ; Omar El-Agnaf [Émirats arabes unis]Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias
000376 Ronald B. Postuma [Canada] ; Jacques Montplaisir [Canada] ; Paola Lanfranchi [Canada] ; Hélène Blais [Canada] ; Sylvie Rompré [Canada] ; Roberto Colombo [Italie] ; Jean-François Gagnon [Canada]Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder
000382 Giovanni Rizzo [Italie] ; Caterina Tonon [Italie] ; Maria Lucia Valentino [Italie] ; David Manners [Italie] ; Filippo Fortuna [Italie] ; Cinzia Gellera [Italie] ; Antonella Pini [Italie] ; Alessandro Ghezzo [Italie] ; Agostino Baruzzi [Italie] ; Claudia Testa [Italie] ; Emil Malucelli [Italie] ; Bruno Barbiroli [Italie] ; Valerio Carelli [Italie] ; Raffaele Lodi [Italie]Brain diffusion‐weighted imaging in Friedreich's ataxia
000387 Maurizio Zibetti [Italie] ; Aristide Merola [Italie] ; Laura Rizzi [Italie] ; Valeria Ricchi [Italie] ; Serena Angrisano [Italie] ; Corrado Azzaro [Italie] ; Carlo Alberto Artusi [Italie] ; Nichy Arduino [Italie] ; Alice Marchisio [Italie] ; Michele Lanotte [Italie] ; Mario Rizzone [Italie] ; Leonardo Lopiano [Italie]Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease
000395 Francesca Assogna [Italie] ; Luca Cravello [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie]Anhedonia in Parkinson's disease: A systematic review of the literature
000397 Michael A. Van Es [Pays-Bas] ; Helenius J. Schelhaas [Pays-Bas] ; Paul W. J. Van Vught [Pays-Bas] ; Nicola Ticozzi [États-Unis, Italie] ; Peter M. Andersen [Suède] ; Ewout J. N. Groen [Pays-Bas] ; Claudia Schulte [Allemagne] ; Hylke M. Blauw [Pays-Bas] ; Max Koppers [Pays-Bas] ; Frank P. Diekstra [Pays-Bas] ; Katsumi Fumoto [Pays-Bas] ; Ashley Lyn Leclerc [États-Unis] ; Pamela Keagle [États-Unis] ; Bastiaan R. Bloem [Pays-Bas] ; Hans Scheffer [Pays-Bas] ; Bart F. L. Van Nuenen [Pays-Bas] ; Marka Van Blitterswijk [Pays-Bas] ; Wouter Van Rheenen [Pays-Bas] ; Anne-Marie Wills [États-Unis] ; Patrick P. Lowe [États-Unis] ; Guo-Fu Hu [États-Unis] ; Wenhao Yu [États-Unis] ; Hiroko Kishikawa [États-Unis] ; David Wu [États-Unis] ; Rebecca D. Folkerth [États-Unis] ; Claudio Mariani [Italie] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Philip Van Damme [Belgique] ; Robin Lemmens [Belgique] ; Caroline Dahlberg [Suède] ; Anna Birve [Suède] ; Rubén Fernández-Santiago [Pays-Bas, Espagne, Allemagne] ; Stefan Waibel [Allemagne] ; Christine Klein [Allemagne] ; Markus Weber [Suisse] ; Anneke J. Van Der Kooi [Pays-Bas] ; Marianne De Visser [Pays-Bas] ; Dagmar Verbaan [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] ; Peter Heutink [Pays-Bas] ; Eric A. M. Hennekam [Pays-Bas] ; Edwin Cuppen [Pays-Bas] ; Daniela Berg [Pays-Bas] ; Robert H. Brown Jr [États-Unis] ; Vincenzo Silani [Italie] ; Thomas Gasser [Allemagne] ; Albert C. Ludolph [Allemagne] ; Wim Robberecht [Belgique] ; Roel A. Ophoff [Pays-Bas, États-Unis] ; Jan H. Veldink [Pays-Bas] ; R. Jeroen Pasterkamp [Pays-Bas] ; Paul I. W. De Bakker [Pays-Bas, États-Unis] ; John E. Landers [États-Unis] ; Bart P. Van De Warrenburg [Pays-Bas] ; Leonard H. Van Den Berg [Pays-Bas]Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
000405 Maurizio Morelli [Italie] ; Gennarina Arabia [Italie] ; Maria Salsone [Italie] ; Fabiana Novellino [Italie] ; Laura Giofrè [Italie] ; Rosina Paletta [Italie] ; Demetrio Messina [Italie] ; Giuseppe Nicoletti [Italie] ; Francesca Condino [Italie] ; Olivier Gallo [Italie] ; Pierluigi Lanza [Italie] ; Aldo Quattrone [Italie]Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease
000414 N. Tambasco ; V. Belcastro [Italie] ; P. Sarchielli ; P. Floridi ; L. Pierguidi [Italie] ; C. Menichetti [Italie] ; A. Castrioto ; P. Chiarini ; L. Parnetti ; P. Eusebi [Italie] ; P. Calabresi [Italie] ; A. RossiA magnetization transfer study of mild and advanced Parkinson’s disease
000430 Silvia Zucchelli ; Marta Codrich ; Federica Marcuzzi ; Milena Pinto ; Sandra Vilotti ; Marta Biagioli ; Isidro Ferrer ; Stefano Gustincich [Italie]TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains
000434 Antonella Conte [Italie] ; Nicola Modugno [Italie] ; Francesco Lena [Italie] ; Sabrina Dispenza [Italie] ; Barbara Gandolfi [Italie] ; Ennio Iezzi [Italie] ; Giovanni Fabbrini [Italie] ; Alfredo Berardelli [Italie]Subthalamic nucleus stimulation and somatosensory temporal discrimination in Parkinsons disease
000436 Pablo Garcia-Reitbck [Royaume-Uni] ; Oleg Anichtchik [Royaume-Uni] ; Arianna Bellucci [Italie] ; Mariangela Iovino [Royaume-Uni] ; Chiara Ballini [Italie] ; Elena Fineberg [Royaume-Uni] ; Bernardino Ghetti [États-Unis] ; Laura Della Corte [Italie] ; Pierfranco Spano [Italie] ; George K. Tofaris [Royaume-Uni] ; Michel Goedert [Royaume-Uni] ; Maria Grazia Spillantini [Royaume-Uni]SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinsons disease
000439 Domenico Corrado [Italie] ; Antonio Pelliccia ; Hein Heidbuchel ; Sanjay Sharma ; Mark Link ; Cristina Basso ; Alessandro Biffi ; Gianfranco Buja [Italie] ; Pietro Delise ; Ihor Gussac ; Aris Anastasakis ; Mats Borjesson ; Hans Halvor Bjrnstad ; Franois Carr ; Asterios Deligiannis ; Dorian Dugmore ; Robert Fagard ; Jan Hoogsteen ; Klaus P. Mellwig ; Nicole Panhuyzen-Goedkoop ; Erik Solberg ; Luc Vanhees ; Jonathan Drezner ; N. A. Mark Estes ; Sabino Iliceto [Italie] ; Barry J. Maron ; Roberto Peidro ; Peter J. Schwartz ; Ricardo Stein ; Gaetano Thiene ; Paolo Zeppilli ; William J. MckennaRecommendations for interpretation of 12-lead electrocardiogram in the athlete
000456 Patrice Pran [Italie, France] ; Andrea Cherubini [Italie] ; Francesca Assogna [Italie] ; Fabrizio Piras [Italie] ; Carlo Quattrocchi [Italie] ; Antonella Peppe [Italie] ; Pierre Celsis [France] ; Olivier Rascol [France] ; Jean-Franois Dmonet [France] ; Alessandro Stefani [Italie] ; Mariangela Pierantozzi [Italie] ; Francesco Ernesto Pontieri [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie] ; Umberto Sabatini [Italie]Magnetic resonance imaging markers of Parkinsons disease nigrostriatal signature
000492 Alessandra Nicoletti [Italie] ; Pierfrancesco Pugliese [Italie] ; Giuseppe Nicoletti [Italie] ; Gennarina Arabia [Italie] ; Grazia Annesi [Italie] ; Michele De Mari [Italie] ; Paolo Lamberti [Italie] ; Lucia Grasso [Italie] ; Roberto Marconi [Italie] ; Antonio Epifanio [Italie] ; Letterio Morgante [Italie] ; Autilia Cozzolino [Italie] ; Paolo Barone [Italie] ; Giusi Torchia [Italie] ; Aldo Quattrone [Italie] ; Mario Zappia [Italie]Voluptuary habits and clinical subtypes of Parkinson's disease: The FRAGAMP case–control study
000516 K. Ray Chaudhuri [Royaume-Uni] ; Cristina Prieto-Jurcynska [Espagne] ; Yogini Naidu [Royaume-Uni] ; Tanya Mitra [Royaume-Uni] ; Belen Frades-Payo [Espagne] ; Susanne Tluk [Royaume-Uni] ; Anne Ruessmann [Allemagne] ; Per Odin [Allemagne] ; Graeme Macphee [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; William Ondo [États-Unis] ; Kapil Sethi [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Juan Carlos Martinez Castrillo [Espagne] ; Pablo Martinez-Martin [Espagne]The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire
000518 Federica Agosta [Italie] ; Vladimir S. Kosti [Serbie] ; Sebastiano Galantucci [Italie] ; Šarlota Mesaroš [Italie, Serbie] ; Marina Svetel [Serbie] ; Elisabetta Pagani [Italie] ; Elka Stefanova [Serbie] ; Massimo Filippi [Italie]The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP‐parkinsonism: a VBM‐DARTEL study
000530 Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis]Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations
000549 Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study
000557 Daniele Lo Coco [Italie] ; Federico Piccoli [Italie] ; Vincenzo La Bella [Italie]Restless legs syndrome in patients with amyotrophic lateral sclerosis
000564 Giuseppe Frazzitta [Italie] ; Roberto Maestri [Italie] ; Gabriella Bertotti [Italie] ; Davide Uccellini [Italie] ; Giacomo Bazzini [Italie] ; Paola Abelli [Italie] ; Roberto Aquilani [Italie]Rehabilitation in Parkinson's disease: Assessing the outcome using objective metabolic measurements
000567 Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
000569 Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000586 Avner Shahar [États-Unis, Israël] ; Kushang V. Patel [États-Unis] ; Richard D. Semba [États-Unis] ; Stefania Bandinelli [Italie] ; Danit R. Shahar [États-Unis, Israël] ; Louigi Ferrucci [États-Unis] ; Jack M. Guralnik [États-Unis]Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speed
000602 Daniela Frosini [Italie] ; Ilaria Pesaresi [Italie] ; Mirco Cosottini [Italie] ; Gina Belmonte [Italie] ; Carlo Rossi [Italie] ; Liliana Dell'Osso [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie] ; Roberto Ceravolo [Italie]Parkinson's Disease and pathological gambling: Results from a functional MRI study
000604 Martin W. I. M. Horstink [Pays-Bas] ; Marieke C. Dekker [Pays-Bas] ; Pasquale Montagna [Italie] ; Vincenzo Bonifati [Pays-Bas] ; Bart P. Van De Warrenburg [Pays-Bas]Pallidopyramidal disease: A misnomer?
000622 Evangelos Evangelou [Grèce, Suisse] ; Demetrius M. Maraganore [États-Unis] ; Grazia Annesi [Italie] ; Laura Brighina [Italie] ; Alexis Brice [France] ; Alexis Elbaz [France] ; Carlo Ferrarese [Italie] ; Georgios M. Hadjigeorgiou [Grèce] ; Rejko Krueger [Allemagne] ; Jean-Charles Lambert [France] ; Suzanne Lesage [France] ; Katerina Markopoulou [Grèce] ; George D. Mellick [Australie] ; Bram Meeus [Belgique] ; Nancy L. Pedersen [Suède] ; Aldo Quattrone [Italie] ; Christine Van Broeckhoven [Belgique] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Eng-King Tan [Singapour] ; Karin Wirdefeldt [Suède] ; John P. A. Ioannidis [Grèce, États-Unis]Non‐replication of association for six polymorphisms from meta‐analysis of genome‐wide association studies of Parkinson's disease: Large‐scale collaborative study
000628 P. Barone [Italie]Neurotransmission in Parkinson’s disease: beyond dopamine
000635 Michele Tinazzi [Italie] ; Serena Recchia [Italie] ; Sara Simonetto [Italie] ; Stefano Tamburin [Italie] ; Giovanni Defazio ; Antonio Fiaschi [Italie] ; Giuseppe Moretto [Italie] ; Massimiliano ValerianiMuscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser‐evoked potentials
000645 Francesco Roselli [Italie, Allemagne] ; Nicola M. Pisciotta [Italie] ; Michele Pennelli [Italie] ; Maria S. Aniello [Italie] ; Angelo Gigante [Italie] ; Maria F. De Caro [Italie] ; Ermanno Ferrannini [Italie] ; Bruno Tartaglione [Italie] ; Artor Niccoli-Asabella [Italie] ; Giovanni Defazio [Italie] ; Paolo Livrea [Italie] ; Giuseppe Rubini [Italie]Midbrain SERT in degenerative parkinsonisms: A 123I‐FP‐CIT SPECT study
000655 Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada]Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease
000668 Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis]Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study
000682 Lena Kertelge [Allemagne] ; Norbert Brüggemann [Allemagne] ; Alexander Schmidt [Allemagne] ; Vera Tadic [Allemagne] ; Claudia Wisse [Allemagne] ; Sylwia Dankert [Allemagne] ; Laura Drude [Allemagne] ; Joyce Van Der Vegt [Allemagne] ; Hartwig Siebner [Allemagne] ; Heike Pawlack [Allemagne] ; Peter P. Pramstaller [Italie] ; Maria Isabel Behrens [Chili] ; Alfredo Ramirez [Allemagne] ; Dirk Reichel [Allemagne] ; Carsten Buhmann [Allemagne] ; Johann Hagenah [Allemagne] ; Christine Klein [Allemagne] ; Katja Lohmann [Allemagne] ; Meike Kasten [Allemagne]Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease
000686 Ioannis U. Isaias [Italie] ; Giorgio Marotta [Italie] ; Shigeki Hirano [États-Unis] ; Margherita Canesi [Italie] ; Riccardo Benti [Italie] ; Andrea Righini [Italie] ; Chengke Tang [États-Unis] ; Roberto Cilia [Italie] ; Gianni Pezzoli [Italie] ; David Eidelberg [États-Unis] ; Angelo Antonini [Italie]Imaging essential tremor
000688 V. Belcastro [Italie] ; L. Pierguidi [Italie] ; A. Castrioto [Italie] ; C. Menichetti [Italie] ; G. Gorgone [Italie] ; R. Ientile ; F. Pisani [Italie] ; A. Rossi [Italie] ; P. Calabresi [Italie] ; N. Tambasco [Italie]Hyperhomocysteinemia recurrence in levodopa‐treated Parkinson’s disease patients
000689 Moonhee Lee [Canada] ; Anna Sparatore [Italie] ; Piero Del Soldato [Italie] ; Edith Mcgeer [Canada] ; Patrick L. Mcgeer [Canada]Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation
000703 Donato Ramani [Italie] ; Chiara Saviane [Italie]Genetic tests: between risks and opportunities
000712 Michelangelo Bartolo [Italie] ; Mariano Serrao [Italie] ; Cristina Tassorelli [Italie] ; Romildo Don [Italie] ; Alberto Ranavolo [Italie] ; Francesco Draicchio [Italie] ; Claudio Pacchetti [Italie] ; Simona Buscone [Italie] ; Armando Perrotta [Italie] ; Anna Furnari [Italie] ; Placido Bramanti [Italie] ; Luca Padua [Italie] ; Francesco Pierelli [Italie] ; Giorgio Sandrini [Italie]Four‐week trunk‐specific rehabilitation treatment improves lateral trunk flexion in Parkinson's disease
000732 Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000740 Francesco E. Pontieri [Italie] ; Carlo Colosimo [Italie]Dopaminergic system in peripheral blood mononuclear cells in Parkinson's disease
000749 Gabriella Santangelo [Italie] ; Carmine Vitale [Italie] ; Luigi Trojano [Italie] ; Danilo De Gaspari [Italie] ; Leonilda Bilo [Italie] ; Angelo Antonini [Italie] ; Paolo Barone [Italie]Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions
000751 C. Rossi ; D. Frosini ; D. Volterrani [Italie] ; P. De Feo ; E. Unti ; V. Nicoletti ; L. Kiferle ; U. Bonuccelli ; R. CeravoloDifferences in nigro‐striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP‐CIT SPECT study
000757 C. Warren Olanow [États-Unis, Italie] ; Karl Kieburtz [États-Unis]Defining disease‐modifying therapies for PD—A road map for moving forward
000761 Michele Poletti [Italie] ; Daniela Frosini [Italie] ; Claudio Lucetti [Italie] ; Paolo Del Dotto [Italie] ; Roberto Ceravolo [Italie] ; Ubaldo Bonuccelli [Italie]Decision making in de novo Parkinson's disease
000763 Ev De Marco [Italie] ; G. Annesi [Italie] ; P. Tarantino [Italie] ; G. Nicoletti [Italie] ; D. Civitelli [Italie] ; D. Messina [Italie] ; F. Annesi [Italie] ; G. Arabia [Italie] ; M. Salsone [Italie] ; F. Condino [Italie] ; F. Novellino [Italie] ; G. Provenzano [Italie] ; Fe Rocca [Italie] ; C. Colica [Italie] ; M. Morelli [Italie] ; V. Scornaienchi [Italie] ; V. Greco [Italie] ; L. Giofrè [Italie] ; A. Quattrone [Italie]DJ‐1 is a Parkinson's disease susceptibility gene in southern Italy
000793 Matteo Marti [Italie] ; Silvio Sarubbo [Italie] ; Francesco Latini [Italie] ; Michele Cavallo [Italie] ; Roberto Eleopra [Italie] ; Sara Biguzzi [Italie] ; Christian Lettieri [Italie] ; Carlo Conti [Italie] ; Michele Simonato [Italie] ; Silvia Zucchini [Italie] ; Rocco Quatrale [Italie] ; Mariachiara Sensi [Italie] ; Sanzio Candeletti [Italie] ; Patrizia Romualdi [Italie] ; Michele Morari [Italie]Brain Interstitial Nociceptin/Orphanin FQ Levels are Elevated in Parkinson's Disease
000796 Elisa Iacovelli [Italie] ; Francesca Gilio [Italie] ; Giuseppe Meco [Italie] ; Francesco Fattapposta [Italie] ; Nicola Vanacore [Italie] ; Livia Brusa [Italie] ; Elena Giacomelli [Italie] ; Maria Gabriele [Italie] ; Alfonso Rubino [Italie] ; Nicoletta Locuratolo [Italie] ; Cesare Iani [Italie] ; Floriana Pichiorri [Italie] ; Carlo Colosimo [Italie] ; Antonio Carbone [Italie] ; Giovanni Palleschi [Italie] ; Maurizio Inghilleri [Italie]Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease
000818 Gennarina Arabia [Italie] ; Maurizio Morelli [Italie] ; Sandra Paglionico [Italie] ; Fabiana Novellino [Italie] ; Maria Salsone [Italie] ; Laura Giofrè [Italie] ; Giusi Torchia [Italie] ; Giuseppe Nicoletti [Italie] ; Demetrio Messina [Italie] ; Francesca Condino [Italie] ; Pierluigi Lanza [Italie] ; Olivier Gallo [Italie] ; Aldo Quattrone [Italie]An magnetic resonance imaging T2*‐weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms
000819 E. Alfonsi [Italie] ; I M Merlo [Italie] ; M. Ponzio [Italie] ; C. Montomoli [Italie] ; C. Tassorelli [Italie] ; C. Biancardi [Italie] ; A. Lozza [Italie] ; E. Martignoni [Italie]An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment
000889 Fiore Manganelli [Italie] ; Carmine Vitale [Italie] ; Gabriella Santangelo [Italie] ; Chiara Pisciotta [Italie] ; Rosa Iodice [Italie] ; Autilia Cozzolino [Italie] ; Raffaele Dubbioso [Italie] ; Marina Picillo [Italie] ; Paolo Barone [Italie] ; Lucio Santoro [Italie]Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease
000911 Simone Guglielmetti [Italie] ; Antonio Nardone [Italie] ; Alessandro Marco De Nunzio [Italie] ; Marco Godi [Italie] ; Marco Schieppati [Italie]Walking along circular trajectories in Parkinson's disease
000915 Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne]Validation of the freezing of gait questionnaire in patients with Parkinson's disease
000925 Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie]Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
000941 Giovanni Defazio [Italie] ; Mar Matarin [États-Unis] ; Elizabeth L. Peckham [États-Unis] ; Davide Martino [Italie] ; Enza M. Valente [Italie] ; Andrew Singleton [États-Unis] ; Anthony Crawley [États-Unis] ; Maria Stella Aniello [Italie] ; Francesco Brancati [Italie] ; Giovanni Abbruzzese [Italie] ; Paolo Girlanda [Italie] ; Paolo Livrea [Italie] ; Mark Hallett [États-Unis] ; Alfredo Berardelli [Italie]The TOR1A polymorphism rs1182 and the risk of spread in primary blepharospasm
000942 Paolo Barone [Italie] ; Angelo Antonini [Italie] ; Carlo Colosimo [Italie] ; Roberto Marconi [Italie] ; Letterio Morgante [Italie] ; Tania P. Avarello [Italie] ; Eugenio Bottacchi [Italie] ; Antonino Cannas [Italie] ; Gabriella Ceravolo [Italie] ; Roberto Ceravolo [Italie] ; Giulio Cicarelli [Italie] ; Roberto M. Gaglio [Italie] ; Rosa M. Giglia [Italie] ; Francesco Iemolo [Italie] ; Michela Manfredi [Italie] ; Giuseppe Meco [Italie] ; Alessandra Nicoletti [Italie] ; Massimo Pederzoli [Italie] ; Alfredo Petrone [Italie] ; Antonio Pisani [Italie] ; Francesco E. Pontieri [Italie] ; Rocco Quatrale [Italie] ; Silvia Ramat [Italie] ; Rosanna Scala [Italie] ; Giuseppe Volpe [Italie] ; Salvatore Zappulla [Italie] ; Anna Rita Bentivoglio [Italie] ; Fabrizio Stocchi [Italie] ; Giorgio Trianni [Italie] ; Paolo Del Dotto [Italie]The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease
000944 Paolo Mazzone [Italie] ; Angelo Insola [Italie] ; Stefano Sposato ; Eugenio Scarnati [Italie]The Deep Brain Stimulation of the Pedunculopontine Tegmental Nucleus
000958 Matthias Elstner [Allemagne] ; Christopher M. Morris [Royaume-Uni] ; Katharina Heim [Allemagne] ; Peter Lichtner [Allemagne] ; Andreas Bender [Allemagne] ; Divya Mehta [Allemagne] ; Claudia Schulte [Allemagne] ; Manu Sharma [Allemagne] ; Gavin Hudson [Royaume-Uni] ; Stefano Goldwurm [Italie] ; Alessandro Giovanetti [Italie] ; Massimo Zeviani [Italie] ; David J. Burn [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] ; Robert H. Perry [Royaume-Uni] ; E. Jaros [Royaume-Uni] ; Rejko Krüger [Allemagne] ; H. Rich Wichmann [Allemagne] ; Stefan Schreiber [Allemagne] ; Harry Campbell [Royaume-Uni] ; James F. Wilson [Royaume-Uni] ; Alan F. Wright [Royaume-Uni] ; Malcolm Dunlop [Royaume-Uni] ; Giorgio Pistis [Italie] ; Daniela Toniolo [Italie] ; Patrick F. Chinnery [Royaume-Uni] ; Thomas Gasser [Allemagne] ; Thomas Klopstock [Allemagne] ; Thomas Meitinger [Allemagne] ; Holger Prokisch [Allemagne] ; Douglass M. Turnbull [Royaume-Uni]Single‐cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene
000970 Luigi M. Romito [Italie] ; Maria Fiorella Contarino [Italie] ; Nicola Vanacore [Italie] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Alberto Albanese [Italie]Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: Long‐term observation
000974 Giuseppe Frazzitta [Italie] ; Roberto Maestri [Italie] ; Davide Uccellini [Italie] ; Gabriella Bertotti [Italie] ; Paola Abelli [Italie]Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: A comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training
000994 A. H. Schapira [Royaume-Uni] ; Yves Agid [France] ; P. Barone [Italie] ; P. Jenner [Royaume-Uni] ; M. R. Lemke [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; H. Reichmann [Allemagne] ; E. Tolosa [Espagne]Perspectives on recent advances in the understanding and treatment of Parkinson’s disease
000A05 Marco D'Amelio [Italie] ; Paolo Ragonese [Italie] ; Gabriella Sconzo [Italie] ; Paolo Aridon [Italie] ; Giovanni Savettieri [Italie]Parkinson's Disease and Cancer
000A11 Giovanni Fabbrini [Italie] ; Giovanni Defazio [Italie] ; Carlo Colosimo [Italie] ; Antonio Suppa [Italie] ; Maria Bloise [Italie] ; Alfredo Berardelli [Italie]Onset and spread of dyskinesias and motor symptoms in Parkinson's disease
000A12 Alessandro Ferraris [Italie] ; Tamara Ialongo [Italie] ; Giulio Cesare Passali [Italie] ; Maria Teresa Pellecchia [Italie] ; Livia Brusa [Italie] ; Marianna Laruffa [Italie] ; Arianna Guidubaldi [Italie] ; Gaetano Paludetti [Italie] ; Alberto Albanese [Italie] ; Paolo Barone [Italie] ; Bruno Dallapiccola [Italie] ; Enza Maria Valente [Italie] ; Anna Rita Bentivoglio [Italie]Olfactory dysfunction in Parkinsonism caused by PINK1 mutations
000A45 Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; Jing Xie [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France]Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease
000A58 Holger Honig [Allemagne] ; Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ian Forgacs [Royaume-Uni] ; Guy C. Faye [Royaume-Uni] ; Thomas Fox [Allemagne] ; Karen Fox [Allemagne] ; Francesca Mancini [Italie] ; Margherita Canesi [Italie] ; Per Odin [Allemagne] ; K. Ray Chaudhuri [Royaume-Uni]Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life
000A66 Stefano Zoccolella [Italie] ; Claudia Dell'Aquila [Italie] ; Giovanni Abruzzese [Italie] ; Angelo Antonini [Italie] ; Ubaldo Bonuccelli [Italie] ; Margherita Canesi [Italie] ; Silvano Cristina [Italie] ; Roberta Marchese [Italie] ; Claudio Pacchetti [Italie] ; Roberto Zagaglia [Italie] ; Giancarlo Logroscino [Italie] ; Giovanni Defazio [Italie] ; Paolo Lamberti [Italie] ; Paolo Livrea [Italie]Hyperhomocysteinemia in levodopa‐treated patients with Parkinson's disease dementia
000A98 Daniele Orsucci [Italie] ; Massimiliano Filosto [Italie] ; Gabriele Siciliano [Italie] ; Michelangelo Mancuso [Italie]Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction
000B05 H. F. Harbo [Norvège] ; J. Finsterer [Autriche] ; J. Baets [Belgique] ; C. Van Broeckhoven [Belgique] ; S. Di Donato [Italie] ; B. Fontaine [France] ; P. De Jonghe [Belgique] ; A. Lossos [Israël] ; T. Lynch [Irlande (pays)] ; C. Mariotti [Italie] ; L. Schöls [Allemagne] ; A. Spinazzola [Italie] ; Z. Szolnoki [Hongrie] ; S. J. Tabrizi [Royaume-Uni] ; C. Tallaksen [Norvège] ; M. Zeviani [Italie] ; J. Burgunder [Suisse] ; T. Gasser [Allemagne]EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington’s disease, Parkinson’s disease and dystonias
000B07 Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse]Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
000B14 Maria Teresa Pellecchia [Italie] ; Paolo Barone [Italie] ; Carmine Mollica [Italie] ; Elena Salvatore [Italie] ; Marta Ianniciello [Italie] ; Katia Longo [Italie] ; Andrea Varrone [Italie] ; Caterina Vicidomini [Italie] ; Marina Picillo [Italie] ; Giuseppe De Michele [Italie] ; Alessandro Filla [Italie] ; Marco Salvatore [Italie] ; Sabina Pappatà [Italie]Diffusion‐weighted imaging in multiple system atrophy: A comparison between clinical subtypes
000B23 Roberta Zangaglia [Italie] ; Claudio Pacchetti [Italie] ; Chiara Pasotti [Italie] ; Francesca Mancini [Italie] ; Domenico Servello [Italie] ; Elena Sinforiani [Italie] ; Silvano Cristina [Italie] ; Marco Sassi [Italie] ; Giuseppe Nappi [Italie]Deep brain stimulation and cognitive functions in Parkinson's disease: A three‐year controlled study
000B31 Fabiana Novellino [Italie] ; Gennarina Arabia [Italie] ; Antonio Bagnato [Italie] ; Giuseppe Lucio Cascini [Italie] ; Maria Salsone [Italie] ; Giuseppe Nicoletti [Italie] ; Demetrio Messina [Italie] ; Maurizio Morelli [Italie] ; Sandra Paglionico [Italie] ; Laura Giofrè [Italie] ; Antonino Restuccia [Italie] ; Giusi Torchia [Italie] ; Francesca Condino [Italie] ; Aldo Quattrone [Italie]Combined use of DAT‐SPECT and cardiac MIBG scintigraphy in mixed tremors
000B35 Gabriella Santangelo [Italie] ; Carmine Vitale [Italie] ; Luigi Trojano [Italie] ; Francesca Verde [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease
000B49 D. Tiple [Italie] ; G. Fabbrini [Italie] ; C. Colosimo [Italie] ; D. Ottaviani [Italie] ; F. Camerota [Italie] ; G. Defazio [Italie] ; A. Berardelli [Italie]Camptocormia in Parkinson disease: an epidemiological and clinical study
000B60 F. R. Guerini [Italie] ; E. Beghi [Italie] ; G. Riboldazzi ; R. Zangaglia ; C. Pianezzola ; G. Bono ; C. Casali [Italie] ; C. Di Lorenzo [Italie] ; C. Agliardi [Italie] ; G. Nappi [Italie] ; M. Clerici [Italie] ; E. Martignoni [Italie]BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease
000B68 Flavio Nobili [Italie] ; Giovanni Abbruzzese [Italie] ; Silvia Morbelli [Italie] ; Roberta Marchese [Italie] ; Nicola Girtler [Italie] ; Barbara Dessi [Italie] ; Andrea Brugnolo [Italie] ; Cinzia Canepa [Italie] ; Giorgos Chr. Drosos [Italie] ; Gianmario Sambuceti [Italie] ; Guido Rodriguez [Italie]Amnestic mild cognitive impairment in Parkinson's disease: A brain perfusion SPECT study
000B72 Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni]Adherence to antiparkinson medication in a multicenter European study
000B84 Matteo Bologna [Italie] ; Rocco Agostino [Italie] ; Bruno Gregori [Italie] ; Daniele Belvisi [Italie] ; Donatella Ottaviani [Italie] ; Carlo Colosimo [Italie] ; Giovanni Fabbrini [Italie] ; Alfredo Berardelli [Italie]Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy
000B88 Maria Nolano [Italie] ; Vincenzo Provitera ; Anna Estraneo ; Mona M. Selim ; Giuseppe Caporaso ; Annamaria Stancanelli ; Anna Maria Saltalamacchia ; Bernardo Lanzillo ; Lucio SantoroSensory deficit in Parkinson's disease: evidence of a cutaneous denervation
000B93 Milena Nasi ; Giovanni Guaraldi ; Gabriella Orlando ; Caterina Durante ; Marcello Pinti ; Elisa Nemes ; Giulia Nardini ; Giuseppe Passarino ; Marina Cocchi ; Roberto Esposito ; Cristina Mussini ; Andrea Cossarizza [Italie]Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy
000C01 Giovanni Rizzo [Italie] ; Paolo Martinelli [Italie] ; David Manners [Italie] ; Cesa Scaglione [Italie] ; Caterina Tonon [Italie] ; Pietro Cortelli [Italie] ; Emil Malucelli [Italie] ; Sabina Capellari [Italie] ; Claudia Testa [Italie] ; Piero Parchi [Italie] ; Pasquale Montagna [Italie] ; Bruno Barbiroli [Italie] ; Raffaele Lodi [Italie]Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease
000C05 Giancarlo Logroscino [Italie] ; Xiang Gao ; Honglei Chen ; Al Wing ; Alberto AscherioDietary Iron Intake and Risk of Parkinson's Disease
000C35 F. Bogazzi [Italie] ; S. Buralli [Italie] ; L. Manetti [Italie] ; V. Raffaelli [Italie] ; T. Cigni [Italie] ; M. Lombardi [Italie] ; F. Boresi [Italie] ; S. Taddei [Italie] ; A. Salvetti [Italie] ; E. Martino [Italie]Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia
000C36 Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis]Treatment of levodopa‐induced motor complications
000C42 Ioannis U. Isaias [Italie] ; Chiara Siri [Italie] ; Roberto Cilia [Italie] ; Danilo De Gaspari [Italie] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie]The relationship between impulsivity and impulse control disorders in Parkinson's disease
000C85 Elena Sinforiani [Italie] ; Claudio Pacchetti [Italie] ; Roberta Zangaglia [Italie] ; Chiara Pasotti [Italie] ; Raffaele Manni [Italie] ; Giuseppe Nappi [Italie]REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: A two‐year follow up
000C94 Eleonora Bazzini [Italie] ; Alberta Samuele [Italie] ; Marcella Granelli [Italie] ; Giovanna Levandis [Italie] ; Marie-Therese Armentero [Italie] ; Giuseppe Nappi [Italie] ; Fabio Blandini [Italie]Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: The synergistic role of dopamine
000D03 Roberto Ceravolo [Italie] ; Angelo Antonini [Italie] ; Duccio Volterrani [Italie] ; Carlo Rossi [Italie] ; Lorenzo Kiferle [Italie] ; Daniela Frosini [Italie] ; Claudio Lucetti [Italie] ; Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie]Predictive value of nigrostriatal dysfunction in isolated tremor: A clinical and SPECT study
000D20 Roberta Marongiu [Italie] ; Alessandro Ferraris [Italie] ; Tàmara Ialongo [Italie] ; Silvia Michiorri [Italie] ; Francesco Soleti [Italie] ; Francesca Ferrari [Italie] ; Antonio E. Elia [Italie] ; Daniele Ghezzi [Italie] ; Alberto Albanese [Italie] ; Maria Concetta Altavista [Italie] ; Angelo Antonini [Italie] ; Paolo Barone [Italie] ; Livia Brusa [Italie] ; Pietro Cortelli [Italie] ; Paolo Martinelli [Italie] ; Maria Teresa Pellecchia [Italie] ; Gianni Pezzoli [Italie] ; Cesa Scaglione [Italie] ; Paolo Stanzione [Italie] ; Michele Tinazzi [Italie] ; Anna Zecchinelli [Italie] ; Massimo Zeviani [Italie] ; Emanuele Cassetta [Italie] ; Barbara Garavaglia [Italie] ; Bruno Dallapiccola [Italie] ; Anna Rita Bentivoglio [Italie] ; Enza Maria Valente [Italie]PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum
000D51 Riccardo Ruffoli [Italie] ; Paola Soldani [Italie] ; Livia Pasquali [Italie] ; Stefano Ruggieri [Italie] ; Antonio Paparelli [Italie] ; Francesco Fornai [Italie]Methamphetamine Fails to Alter the Noradrenergic Integrity of the Heart
000D64 Vania Gelmetti [Italie] ; Alessandro Ferraris [Italie] ; Livia Brusa [Italie] ; Francesca Romano [Italie] ; Federica Lombardi [Italie] ; Chiara Barzaghi [Italie] ; Paolo Stanzione [Italie] ; Barbara Garavaglia [Italie] ; Bruno Dallapiccola [Italie] ; Enza Maria Valente [Italie]Late onset sporadic Parkinson's disease caused by PINK1 mutations: Clinical and functional study
000D68 Rocco Agostino [Italie] ; Loredana Dinapoli [Italie] ; Nicola Modugno [Italie] ; Ennio Iezzi [Italie] ; Bruno Gregori [Italie] ; Vincenzo Esposito [Italie] ; Pantaleo Romanelli [Italie] ; Alfredo Berardelli [Italie]Ipsilateral sequential arm movements after unilateral subthalamic deep‐brain stimulation in patients with Parkinson's disease
000D77 Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Peter P. Pramstaller [Italie] ; Jomana Al-Hinti [États-Unis] ; Anette T. Moller [Danemark] ; Karen Ostergaard [Danemark] ; Scott J. Sherman [États-Unis] ; Richard Roxburgh [Nouvelle-Zélande] ; Barry Snow [Nouvelle-Zélande] ; John T. Slevin [États-Unis] ; Franca Cambi [États-Unis] ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis]Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study
000E24 Werner Poewe [Autriche] ; S. Gauthier [Canada] ; D. Aarsland [Norvège] ; J. B. Leverenz [États-Unis] ; P. Barone [Italie] ; D. Weintraub [États-Unis] ; E. Tolosa [Espagne] ; B. Dubois [France]Diagnosis and management of Parkinson’s disease dementia
000E33 Angelo Antonini [Italie] ; Patrizia Berto [Italie] ; Stefania Lopatriello [Italie] ; Filippo Tamma [Italie] ; Lieven Annemans [Belgique] ; Mike Chambers [Royaume-Uni]Cost‐effectiveness of 123I‐FP‐CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy
000E50 R. Cilia [Italie] ; G. Marotta [Italie] ; A. Landi [Italie] ; I. U. Isaias [Italie] ; F. Vergani [Italie] ; R. Benti [Italie] ; E. Sganzerla [Italie] ; P. Gerundini [Italie] ; G. Pezzoli [Italie] ; A. Antonini [Italie]Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: a perfusion SPECT study
000E57 L. Bet [Italie] ; S. R. Bareggi [Italie] ; F. Pacei [Italie] ; G. Bondiolotti [Italie] ; G. Meola [Italie] ; A. H. V. Schapira [Royaume-Uni]Bimodal administration of entacapone in Parkinson’s disease patients improves motor control
000E59 Anna R. Carta [Italie] ; Frau Lucia [Italie] ; Pinna Annalisa [Italie] ; Pontis Silvia [Italie] ; Simola Nicola [Italie] ; Schintu Nicoletta [Italie] ; Morelli Micaela [Italie]Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6‐OHDA lesioned rat
000E65 Giuseppe Nicoletti [Italie] ; Caterina Tonon [Italie] ; Raffaele Lodi [Italie] ; Francesca Condino [Italie] ; David Manners [Italie] ; Emil Malucelli [Italie] ; Maurizio Morelli [Italie] ; Fabiana Novellino [Italie] ; Sandra Paglionico [Italie] ; Pierluigi Lanza [Italie] ; Demetrio Messina [Italie] ; Paolo Barone [Italie] ; Letterio Morgante [Italie] ; Mario Zappia [Italie] ; Bruno Barbiroli [Italie] ; Aldo Quattrone [Italie]Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease
000E69 Bart P. C. Van De Warrenburg [Royaume-Uni, Pays-Bas] ; Andrew J. Church [Royaume-Uni] ; Davide Martino [Royaume-Uni, Italie] ; Paul M. Candler [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni]Antineuronal antibodies in Parkinson's disease
000E70 Alessandro M. De Nunzio [Italie] ; Antonio Nardone [Italie] ; Daniele Picco [Italie] ; Jan Nilsson [Italie] ; Marco Schieppati [Italie]Alternate trains of postural muscle vibration promote cyclic body displacement in standing parkinsonian patients
000E71 E. V. De Marco [Italie] ; P. Tarantino [Italie] ; F. E. Rocca [Italie] ; G. Provenzano [Italie] ; D. Civitelli [Italie] ; V. De Luca [Italie] ; F. Annesi [Italie] ; S. Carrideo [Italie] ; I. C. Cir Candiano [Italie] ; N. Romeo [Italie] ; G. Nicoletti [Italie] ; R. Marconi [Italie] ; F. Novellino [Italie] ; M. Morelli [Italie] ; A. Quattrone [Italie] ; G. Annesi [Italie]Alpha‐synuclein promoter haplotypes and dementia in Parkinson's Disease
000E78 C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France]A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
000F13 Roberta Marongiu [Italie] ; Francesco Brancati [Italie] ; Angelo Antonini [Italie] ; Tamara Ialongo [Italie] ; Caterina Ceccarini [Italie] ; Oronzo Scarciolla [Italie] ; Anna Capalbo [Italie] ; Riccardo Benti [Italie] ; Gianni Pezzoli [Italie] ; Bruno Dallapiccola [Italie] ; Stefano Goldwurm [Italie] ; Enza Maria Valente [Italie]Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum
000F27 Fabio Blandini [Italie] ; Giovanna Levandis [Italie] ; Eleonora Bazzini [Italie] ; Giuseppe Nappi [Italie] ; Marie-Therese Armentero [Italie]Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model
000F31 Mauro Fasano [Italie] ; Bruno Bergamasco [Italie] ; Leonardo Lopiano [Italie]The proteomic approach in Parkinson's disease
000F35 Nadia Rosenthal [Italie] ; Steve Brown [Royaume-Uni]The mouse ascending: perspectives for human-disease models
000F37 Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Richard G. Brown [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] ; Per Odin [Allemagne] ; William Ondo [États-Unis] ; Kazuo Abe [Japon] ; Graeme Macphee [Royaume-Uni] ; Doug Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Warren Olanow [États-Unis] ; Adrian J. Williams [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Yoshio Tsuboi [Japon] ; Annette Hand [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni]The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study
000F47 Paolo Barone [Italie] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Zoe Clarke [Royaume-Uni]Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease
000F61 Christoph Scherfler [Autriche] ; Johannes Schwarz [Allemagne] ; Angelo Antonini [Italie] ; Donald Grosset [Royaume-Uni] ; Francesc Valldeoriola [Espagne] ; Kenneth Marek [États-Unis] ; Wolfgang Oertel [Allemagne] ; Eduardo Tolosa [Espagne] ; Andrew Lees (neurologue) [Royaume-Uni] ; Werner Poewe [Autriche]Role of DAT‐SPECT in the diagnostic work up of Parkinsonism
000F71 Ana Djarmati [Allemagne] ; Miodrag Gužvi [Allemagne, Serbie] ; Anne Grünewald [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; David K. Simon [États-Unis] ; Angela M. Kaindl [Allemagne] ; Peter Vieregge [Allemagne] ; Anders O. H. Nygren [Pays-Bas] ; Christian Beetz [Allemagne] ; Katja Hedrich [Allemagne] ; Christine Klein [Allemagne]Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation‐dependent probe amplification
000F84 Andrew J. Lawrence [Royaume-Uni] ; Andrew D. Blackwell [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Francesca Spagnolo [Italie] ; Luke Clark [Royaume-Uni] ; Michael R. F. Aitken [Royaume-Uni] ; Barbara J. Sahakian [Royaume-Uni]Predictors of punding in Parkinson's disease: Results from a questionnaire survey
001001 Francesca Del Sorbo [Italie] ; Antonio E. Elia [Italie] ; Gabriella De Joanna [Italie] ; Luigi M. Romito [Italie] ; Barbara Garavaglia [Italie] ; Alberto Albanese [Italie]Normal cardiovascular reflex testing in patients with parkin disease
001005 Maria Teresa Giordana [Italie] ; Carla D'Agostino [Italie] ; Giovanni Albani [Italie] ; Alessandro Mauro [Italie] ; Alessio Di Fonzo [Pays-Bas, Italie] ; Angelo Antonini [Italie] ; Vincenzo Bonifati [Pays-Bas]Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation
001012 Michelle L. Block [États-Unis] ; Luigi Zecca [Italie] ; Jau-Shyong Hong [États-Unis]Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
001015 Stefano Zoccolella [Italie] ; Giovanni Iliceto [Italie] ; Michele Demari [Italie] ; Paolo Livrea [Italie] ; Paolo Lamberti [Italie]Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review
001018 Roberta Zangaglia [Italie] ; Emilia Martignoni [Italie] ; Margaret Glorioso [Italie] ; Maria Ossola [Italie] ; Giulio Riboldazzi [Italie] ; Daniela Calandrella [Italie] ; Gabriele Brunetti [Italie] ; Claudio Pacchetti [Italie]Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo‐controlled study
001027 Giovanni Fabbrini [Italie] ; Jonathan M. Brotchie [Canada] ; Francisco Grandas [Espagne] ; Masahiro Nomoto [Japon] ; Christopher G. Goetz [États-Unis]Levodopa‐induced dyskinesias
001035 Claudio Lucetti [Italie] ; Paulo Del Dotto [Italie] ; Gianna Gambaccini [Italie] ; Roberto Ceravolo [Italie] ; Chiara Logi [Italie] ; Caterina Berti [Italie] ; Giuseppe Rossi [Italie] ; Maria Cristina Bianchi [Italie] ; Michela Tosetti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie]Influences of dopaminergic treatment on motor cortex in Parkinson disease: A MRI/MRS study
001041 Roberto G. Lucchini [Italie] ; Elisa Albini [Italie] ; Laura Benedetti [Italie] ; Stefano Borghesi [Italie] ; Romana Coccaglio [Italie] ; Eros C. Malara [Italie] ; Giovanni Parrinello [Italie] ; Siria Garattini [Italie] ; Sergio Resola [Italie] ; Lorenzo Alessio [Italie]High prevalence of parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries
001044 Paolo Ragonese [Italie] ; Marco D'Amelio [Italie] ; Graziella Callari [Italie] ; Fabio Aiello [Italie] ; Letterio Morgante [Italie] ; Giovanni Savettieri [Italie]Height as a potential indicator of early life events predicting Parkinson's disease: A case‐control study
001045 Lawrence I. Golbe [États-Unis] ; Giuseppe Di Iorio [Italie] ; Katerina Markopoulou [Grèce] ; Aglaia Athanassiadou [Grèce] ; Spiridon Papapetropoulos [États-Unis] ; Ray L. Watts [États-Unis] ; Jeffery M. Vance [États-Unis] ; Vincenzo Bonifati [Pays-Bas] ; Tanishia A. Williams [États-Unis] ; John R. Spychala [États-Unis] ; E. Scot Stenroos [États-Unis] ; Williams G. Johnson [États-Unis]Glutathione S‐transferase polymorphisms and onset age in α‐synuclein A53T mutant Parkinson's disease
001053 Ulrich R. M. Bohr [Allemagne] ; Bruno Annibale [Italie] ; Francesco Franceschi [Italie] ; Davide Roccarina [Italie] ; Antonio Gasbarrini [Italie]Extragastric Manifestations of Helicobacter pylori Infection – Other Helicobacters
001054 Roberto Cilia [Italie] ; Andrea Landi [Italie] ; Francesco Vergani [Italie] ; Erik Sganzerla [Italie] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie]Extradural motor cortex stimulation in Parkinson's disease
001066 Angelo Antonini [Italie] ; Ioannis U. Isaias [Italie] ; Margherita Canesi [Italie] ; Maurizio Zibetti [Italie] ; Francesca Mancini [Italie] ; Luigi Manfredi [Italie] ; Marco Dal Fante [Italie] ; Leonardo Lopiano [Italie] ; Gianni Pezzoli [Italie]Duodenal levodopa infusion for advanced Parkinson's disease: 12‐month treatment outcome
001080 Anette Schrag [Royaume-Uni] ; Paolo Barone [Italie] ; Richard G. Brown [Royaume-Uni] ; Albert F. G. Leentjens [Pays-Bas] ; William M. Mcdonald [États-Unis] ; Sergio Starkstein [Australie] ; Daniel Weintraub [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Depression rating scales in Parkinson's disease: Critique and recommendations
001124 Annalisa Pinna [Italie] ; Silvia Pontis [Italie] ; Franco Borsini [Italie] ; Micaela Morelli [Italie]Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6‐hydroxydopamine rat model of Parkinson's disease
001134 Gabriella Santangelo [Italie] ; Luigi Trojano [Italie] ; Carmine Vitale [Italie] ; Marta Ianniciello [Italie] ; Marianna Amboni [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations
001156 Giuseppe Nicoletti [Italie] ; Raffaele Lodi [Italie] ; Francesca Condino [Italie] ; Caterina Tonon [Italie] ; Francesco Fera [Italie] ; Emil Malucelli [Italie] ; David Manners [Italie] ; Mario Zappia [Italie] ; Letterio Morgante [Italie] ; Paolo Barone [Italie] ; Bruno Barbiroli [Italie] ; Aldo Quattrone [Italie]Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy
001180 M. Sharma [Allemagne] ; J C Mueller [Allemagne] ; A. Zimprich [Autriche] ; P. Lichtner [Allemagne] ; A. Hofer [Allemagne] ; P. Leitner [Allemagne] ; S. Maass [Allemagne] ; D. Berg [Allemagne] ; A. Dürr [France] ; V. Bonifati [Italie] ; G. De Michele [Pays-Bas] ; B. Oostra [Italie] ; A. Brice [France] ; N W Wood [Royaume-Uni] ; B. Muller-Myhsok [Allemagne] ; T. Gasser [Allemagne]The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson’s disease in European populations
001185 Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
001194 Galit Kleiner-Fisman [États-Unis] ; Jan Herzog [Allemagne] ; David N. Fisman [États-Unis] ; Filippo Tamma [Italie] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne]Subthalamic nucleus deep brain stimulation: Summary and meta‐analysis of outcomes
001196 Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Stefano Goldwurm [Italie] ; Michela Zini [Italie] ; Roberto Cilia [Italie] ; Paolo Gerundini [Italie] ; Alessio Di Fonzo [Pays-Bas, Italie] ; Vincenzo Bonifati [Pays-Bas, Italie] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie]Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation
001206 M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal]Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease
001207 M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal]Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease
001209 Katja Hedrich [Allemagne] ; Susen Winkler [Allemagne] ; Johann Hagenah [Allemagne] ; Kemal Kabakci [Allemagne] ; Meike Kasten [Allemagne] ; Eberhard Schwinger [Allemagne] ; Jens Volkmann [Allemagne] ; Peter P. Pramstaller [Italie] ; Vladimir Kostic [Yougoslavie] ; Peter Vieregge [Allemagne] ; Christine Klein [Allemagne]Recurrent LRRK2 (Park8) mutations in early‐onset Parkinson's disease
001211 F. Stocchi [Italie]Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease
001213 Angelo Antonini [Italie] ; Silvana Tesei [Italie] ; Anna Zecchinelli [Italie] ; Paolo Barone [Italie] ; Danilo De Gaspari [Italie] ; Margherita Canesi [Italie] ; Giorgio Sacilotto [Italie] ; Nicoletta Meucci [Italie] ; Claudio Mariani [Italie] ; Gianni Pezzoli [Italie]Randomized study of sertraline and low‐dose amitriptyline in patients with Parkinson's disease and depression: Effect on quality of life
001221 Felix Geser [Autriche] ; Gregor K. Wenning [Autriche] ; Klaus Seppi [Autriche] ; Michaela Stampfer-Kountchev [Autriche] ; Christoph Scherfler [Autriche] ; Martin Sawires [Autriche] ; Carolin Frick [Autriche] ; Jean-Pierre Ndayisaba [Autriche] ; Hanno Ulmer [Autriche] ; Maria T. Pellecchia [Italie] ; Paolo Barone [Italie] ; Hee T. Kim [Royaume-Uni] ; Juzar Hooker [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Adriana Cardozo [Espagne] ; Eduardo Tolosa [Espagne] ; Michael Abele [Allemagne] ; Thomas Klockgether [Allemagne] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Nicole Schimke [Allemagne] ; Karla M. Eggert [Allemagne] ; Wolfgang Oertel [Allemagne] ; Ruth Djaldetti [Israël] ; Werner Poewe [Autriche]Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG)
001235 Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne]Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study
001243 M. Tinazzi [Italie] ; C. Del Vesco [Italie] ; E. Fincati ; S. Ottaviani ; N. Smania [Italie] ; G. Moretto ; A. Fiaschi [Italie] ; D. Martino [Italie] ; G. Defazio [Italie]Pain and motor complications in Parkinson’s disease
001257 Pablo Iba N Ez ; Suzanne Lesage ; Ebba Lohmann ; Ste Phane Thobois ; Giuseppe De Michele [Italie] ; Michel Borg ; Yves Agid [France] ; Alexandra Du Rr ; Alexis BriceMutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa
001277 Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Anthony H. V. Schapira [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; Kapil Sethi [États-Unis] ; Per Odin [Allemagne] ; Richard G. Brown [Royaume-Uni] ; William Koller [États-Unis] ; Paolo Barone [Italie] ; Graeme Macphee [Royaume-Uni] ; Linda Kelly [Royaume-Uni] ; Martin Rabey [Israël] ; Doug Macmahon [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; William Ondo [États-Unis] ; David Rye [États-Unis] ; Alison Forbes [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Vandana Dhawan [Royaume-Uni] ; Annette Bowron [Royaume-Uni] ; Adrian J. Williams [Royaume-Uni] ; Charles W. Olanow [États-Unis]International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
001281 A. Cagnin [Italie] ; M. Kassiou [Australie] ; S. R. Meikle [Australie] ; R. B. Banati [Australie]In vivo evidence for microglial activation in neurodegenerative dementia
001282 Paolo Ragonese [Italie] ; Marco D'Amelio [Italie] ; Giovanni Savettieri [Italie]Implications for Estrogens in Parkinson's Disease
001321 A. Padovani [Italie] ; B. Borroni [Italie] ; S M Brambati [Italie] ; C. Agosti [Italie] ; M. Broli [Italie] ; R. Alonso [Italie] ; P. Scifo [Italie] ; G. Bellelli [Italie] ; A. Alberici [Italie] ; R. Gasparotti [Italie] ; D. Perani [Italie]Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy
001328 Günther Deuschl [Allemagne] ; Jan Herzog [Allemagne] ; Galit Kleiner-Fisman [États-Unis] ; Cynthia Kubu [États-Unis] ; Andres M. Lozano [Canada] ; Kelly E. Lyons [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Filippo Tamma [Italie] ; Alexander I. Tröster [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Jens Volkmann [Allemagne] ; Valerie Voon [États-Unis]Deep brain stimulation: Postoperative issues
001339 D. De Gaspari [Italie] ; C. Siri [Italie] ; A. Landi [Italie] ; R. Cilia [Italie] ; A. Bonetti [Italie] ; F. Natuzzi [Italie] ; L. Morgante [Italie] ; C B Mariani [Italie] ; E. Sganzerla [Italie] ; G. Pezzoli [Italie] ; A. Antonini [Italie]Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson’s disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus
001349 Paolo Mazzone [Italie] ; Fabrizio Stocchi [Italie] ; Salvatore Galati [Italie] ; Angelo Insola [Italie] ; Maria Grazia Altibrandi [Italie] ; Nicola Modugno [Italie] ; Domenicantonio Tropepi [Italie] ; Livia Brusa [Italie] ; Alessandro Stefani [Italie]Bilateral Implantation of Centromedian‐Parafascicularis Complex and GPi: A New Combination of Unconventional Targets for Deep Brain Stimulation in Severe Parkinson Disease
001363 Giuseppina Candore [Italie] ; Carmela R. Balistreri [Italie] ; Maria P. Grimaldi [Italie] ; Sonya Vasto [Italie] ; Florinda Listì [Italie] ; Martina Chiappelli [Italie] ; Federico Licastro [Italie] ; Domenico Lio [Italie] ; Calogero Caruso [Italie]Age‐Related Inflammatory Diseases
001408 S. Goldwurm [Italie] ; A Di Fonzo [Italie] ; E J Simons [Pays-Bas] ; C F Rohé [Pays-Bas] ; M. Zini [Italie] ; M. Canesi [Italie] ; S. Tesei [Italie] ; A. Zecchinelli [Italie] ; A. Antonini [Italie] ; C. Mariani [Italie] ; N. Meucci [Italie] ; G. Sacilotto [Italie] ; F. Sironi [Italie] ; G. Salani [Italie] ; J. Ferreira [Portugal] ; H F Chien [Brésil] ; E. Fabrizio [Italie] ; N. Vanacore [Italie] ; A Dalla Libera [Italie] ; F. Stocchi [Italie] ; C. Diroma [Italie] ; P. Lamberti [Italie] ; C. Sampaio [Portugal] ; G. Meco [Italie] ; E. Barbosa [Brésil] ; A M Bertoli-Avella [Pays-Bas] ; G J Breedveld [Pays-Bas] ; B A Oostra [Pays-Bas] ; G. Pezzoli [Italie] ; V. Bonifati [Pays-Bas]The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor
001420 Angelo Insola [Italie] ; Paolo Mazzone [Italie] ; Massimiliano Valeriani [Italie]Somatosensory evoked potential and clinical changes after electrode implant in basal ganglia of parkinsonian patients
001433 Claudio Pacchetti [Italie] ; Raffaele Manni [Italie] ; Roberta Zangaglia [Italie] ; Francesca Mancini [Italie] ; Enrico Marchioni [Italie] ; Cristina Tassorelli [Italie] ; Michele Terzaghi [Italie] ; Maria Ossola [Italie] ; Emilia Martignoni [Italie] ; Arrigo Moglia [Italie] ; Giuseppe Nappi [Italie]Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease
001438 Tomaso Scaravilli [Italie] ; Eduardo Tolosa [Espagne] ; Isidre Ferrer [Espagne]Progressive supranuclear palsy and corticobasal degeneration: Lumping versus splitting
001440 R. Totaro [Italie] ; C. Marini [Italie] ; F. Pistoia [Italie] ; S. Sacco [Italie] ; T. Russo [Italie] ; A. Carolei [Italie]Prevalence of Parkinson's disease in the L'Aquila district, central Italy
001452 Aida M. Bertoli-Avella [Pays-Bas] ; José L. Giroud-Benitez [Cuba] ; Ali Akyol [Turquie] ; Egberto Barbosa [Brésil] ; Onno Schaap [Pays-Bas] ; Herma C. Van Der Linde [Pays-Bas] ; Emilia Martignoni [Italie] ; Leonardo Lopiano [Italie] ; Paolo Lamberti [Italie] ; Emiliana Fincati [Italie] ; Angelo Antonini [Italie] ; Fabrizio Stocchi [Italie] ; Pasquale Montagna [Italie] ; Ferdinando Squitieri [Italie] ; Paolo Marini [Italie] ; Giovanni Abbruzzese [Italie] ; Giovanni Fabbrini [Italie] ; Roberto Marconi [Italie] ; Alessio Dalla Libera [Italie] ; Giorgio Trianni [Italie] ; Marco Guidi [Italie] ; Antonio De Gaetano [Italie] ; Gustavo Boff Maegawa [Brésil] ; Antonino De Leo [Italie] ; Virgilio Gallai [Italie] ; Giulia De Rosa [Italie] ; Nicola Vanacore [Italie] ; Giuseppe Meco [Italie] ; Cornelia M. Van Duijn [Pays-Bas] ; Ben A. Oostra [Pays-Bas] ; Peter Heutink [Pays-Bas] ; Vincenzo Bonifati [Pays-Bas, Italie]Novel parkin mutations detected in patients with early‐onset Parkinson's disease
001469 J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Jürgen Köster [Allemagne] ; Gianni Pezzoli [Italie] ; Leandro Provinciali [Italie]Long‐term efficacy and safety of pramipexole in advanced Parkinson's disease: Results from a European multicenter trial
001470 Peter P. Pramstaller [Italie, Allemagne] ; Michael G. Schlossmacher [États-Unis] ; Thomas S. Jacques [Royaume-Uni] ; Francesco Scaravilli [Royaume-Uni] ; Cordula Eskelson [Allemagne] ; Imelda Pepivani [États-Unis] ; Katja Hedrich [Allemagne] ; Susanna Adel [Allemagne] ; Melissa Gonzales-Mcneal [États-Unis] ; Rüdiger Hilker [Allemagne] ; Patricia L. Kramer [États-Unis] ; Christine Klein [Allemagne]Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers
001481 Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie]Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment
001493 Dario Grossi [Italie] ; Luigi Trojano [Italie] ; Maria Teresa Pellecchia [Italie] ; Marianna Amboni [Italie] ; Nina Antonetta Fragassi [Italie] ; Paolo Barone [Italie]Frontal dysfunction contributes to the genesis of hallucinations in non‐demented Parkinsonian patients
001502 Annamaria Colao ; Rosario Pivonello ; Paolo Cappabianca ; Francesco Briganti [Italie] ; Fabio Tortora [Italie] ; Renata S. Auriemma ; Maria Cristina De Martino ; Paolo Marzullo ; Gaetano LombardiEffect of gender and gonadal status on the long‐term response to somatostatin analogue treatment in acromegaly
001555 Guglielmo Foffani [Italie, États-Unis] ; Anna M. Bianchi [Italie] ; Alberto Priori [Italie] ; Giuseppe Baselli [Italie]Adaptive autoregressive identification with spectral power decomposition for studying movement-related activity in scalp EEG signals and basal ganglia local field potentials
001574 Fabio Guerini [Italie] ; Giovanni B. Frisoni [Italie] ; Catherine Bellwald [Italie] ; Roberta Rossi Psy [Italie] ; Giuseppe Bellelli [Italie] ; Marco Trabucchi [Italie]Subcortical Vascular Lesions Predict Functional Recovery After Rehabilitation in Patients with L‐Dopa Refractory Parkinsonism
001585 A. Nuti ; R. Ceravolo ; A. Piccinni [Italie] ; G. Dell'Agnello ; G. Bellini ; G. Gambaccini ; C. Rossi ; C. Logi ; L. Dell'Osso [Italie] ; U. BonuccelliPsychiatric comorbidity in a population of Parkinson's disease patients
001587 Adolfo Brusa [Italie] ; Rolf Stoehr [Italie] ; Peter P. Pramstaller [Italie]Progressive supranuclear palsy: New disease or variant of postencephalitic parkinsonism?
001595 Enza Maria Valente [Italie] ; Sergio Salvi [Italie] ; Tamara Ialongo [Italie] ; Roberta Marongiu [Italie] ; Antonio Emanuele Elia [Italie] ; Viviana Caputo [Italie] ; Luigi Romito [Italie] ; Alberto Albanese [Italie] ; Bruno Dallapiccola [Italie] ; Anna Rita Bentivoglio [Italie]PINK1 mutations are associated with sporadic early‐onset parkinsonism
001604 Alessandro Buccolieri [Italie] ; Laura Avanzino [Italie] ; Lucio Marinelli [Italie] ; Carlo Trompetto [Italie] ; Roberta Marchese [Italie] ; Giovanni Abbruzzese [Italie]Muscle relaxation is impaired in dystonia: A reaction time study
001613 C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]Levodopa in the treatment of Parkinson's disease: Current controversies
001617 Luigi Zecca [Italie] ; Moussa B. H. Youdim [Israël] ; Peter Riederer [Allemagne] ; James R. Connor [États-Unis] ; Robert R. Crichton [Belgique]Iron, brain ageing and neurodegenerative disorders
001629 M. Martinez [France] ; A. Brice [France] ; J R Vaughan [Royaume-Uni] ; A. Zimprich [Allemagne] ; M M B. Breteler [Pays-Bas] ; G. Meco [Italie] ; A. Filla [Italie] ; M J Farrer [États-Unis] ; C. Bétard [France] ; J. Hardy [États-Unis] ; G. De Michele [Italie] ; V. Bonifati [Italie] ; B. Oostra [Pays-Bas] ; T. Gasser [Allemagne] ; N W Wood [Royaume-Uni] ; A. Dürr [France]Genome-wide scan linkage analysis for Parkinson’s disease: the European genetic study of Parkinson’s disease
001652 Katja Hedrich [Allemagne] ; Cordula Eskelson [Allemagne] ; Beth Wilmot [États-Unis] ; Karen Marder [États-Unis] ; Juliette Harris [États-Unis] ; Jennifer Garrels [Allemagne] ; Helen Meija-Santana [États-Unis] ; Peter Vieregge [Allemagne] ; Helfried Jacobs [Allemagne] ; Susan B. Bressman [États-Unis] ; Anthony E. Lang [Canada] ; Martin Kann [Allemagne] ; Giovanni Abbruzzese [Italie] ; Paolo Martinelli [Italie] ; Eberhard Schwinger [Allemagne] ; Laurie J. Ozelius [États-Unis] ; Peter P. Pramstaller [Italie, États-Unis] ; Christine Klein [Allemagne] ; Patricia Kramer [États-Unis]Distribution, type, and origin of Parkin mutations: Review and case studies
001660 Paola Costa-Mallen [États-Unis] ; Zahra Afsharinejad [États-Unis] ; Samir N. Kelada [États-Unis] ; Lucio G. Costa [États-Unis, Italie] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; W. T. Longstreth Jr. [États-Unis] ; Hannah-Malia A. Viernes [États-Unis] ; Federico M. Farin [États-Unis] ; Terri Smith-Weller [États-Unis] ; Harvey Checkoway [États-Unis]DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls
001700 Maria G. Macedo ; Burcu Anar ; Iraad F. Bronner ; Milena Cannella ; Ferdinando Squitieri ; Vincenzo Bonifati [Italie] ; Andre Hoogeveen ; Peter Heutink ; Patrizia RizzuThe DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes
001705 Aida M. Bertoli-Avella [Pays-Bas, Cuba] ; Jose L. Giroud-Benitez [Cuba] ; Vincenzo Bonifati [Italie, Pays-Bas] ; Eduardo Alvarez-Gonzalez [Cuba] ; Luis Heredero-Baute [Cuba] ; Cornelia M. Van Duijn [Pays-Bas] ; Peter Heutink [Pays-Bas]Suggestive linkage to chromosome 19 in a large Cuban family with late‐onset Parkinson's disease
001736 Fabrizio Stocchi [Italie] ; C. Warren Olanow [États-Unis]Neuroprotection in Parkinson's disease: Clinical trials
001757 Ebba Lohmann [France] ; Magali Periquet [France] ; Vincenzo Bonifati [Italie] ; Nick W. Wood [Royaume-Uni] ; Giuseppe De Michele [Italie] ; Anne-Marie Bonnet [France] ; Valérie Fraix [France] ; Emmanuel Broussolle [France] ; Martin W. I. M. Horstink [Pays-Bas] ; Marie Vidailhet [France] ; Patrice Verpillat [France] ; Thomas Gasser [Allemagne] ; David Nicholl [Royaume-Uni] ; Hélio Teive [Brésil] ; Salmo Raskin [Brésil] ; Olivier Rascol [France] ; Alain Destée [France] ; Merle Ruberg [France] ; Francesca Gasparini [France] ; Giuseppe Meco [Italie] ; Yves Agid [France] ; Alexandra Durr [France] ; Alexis Brice [France]How much phenotypic variation can be attributed to parkin genotype?
001784 A. Albanese [Italie] ; C. Colosimo [Italie]Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists
001809 Stefano Tamburin [Italie] ; Antonio Fiaschi [Italie] ; Domenico Idone [Italie] ; Piergiorgio Lochner [Italie] ; Paolo Manganotti [Italie] ; Giampietro Zanette [Italie]Abnormal sensorimotor integration is related to disease severity in Parkinson's disease: A TMS study
001827 K R Chaudhuri [Royaume-Uni] ; S. Pal [Royaume-Uni] ; A. Dimarco [Royaume-Uni] ; C. Whately-Smith ; K. Bridgman [Royaume-Uni] ; R. Mathew [Royaume-Uni] ; F R Pezzela [Italie] ; A. Forbes [Royaume-Uni] ; B. Högl [Allemagne] ; C. Trenkwalder [Allemagne]The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease
001830 Andrew Feigin [États-Unis] ; Angelo Antonini [Italie] ; Masafumi Fukuda [États-Unis] ; Roberta De Notaris [Italie] ; Riccardo Benti [Italie] ; Gianni Pezzoli [Italie] ; Marc J. Mentis [États-Unis] ; James R. Moeller [États-Unis] ; David Eidelberg [États-Unis]Tc‐99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism
001842 V. Calabrese [Italie] ; G. Scapagnini [Italie, États-Unis] ; A. Ravagna [Italie] ; R. G. Fariello [États-Unis, Italie] ; A. M. Giuffrida Stella [Italie] ; N. G. Abraham [États-Unis]Regional distribution of heme oxygenase, HSP70, and glutathione in brain: Relevance for endogenous oxidant/antioxidant balance and stress tolerance
001872 Ferdinando Rossi [Italie] ; Elena Cattaneo [Italie]Neural stem cell therapy for neurological diseases: dreams and reality
001892 M. Zorzon [Italie] ; L. Capus [Italie] ; A. Pellegrino [Italie] ; G. Cazzato [Italie] ; R. Zivadinov [Italie]Familial and environmental risk factors in Parkinson's disease: a case–control study in north‐east Italy
001894 Fabrizio Drago [Italie] ; Massimo Stefano Silvetti [Italie] ; Alfredo Di Pino [Italie] ; Giorgia Grutter [Italie] ; Maurizio Bevilacqua [Italie] ; Shoshana Leibovich [Italie]Exclusion of Fluoroscopy During Ablation Treatment of Right Accessory Pathway in Children
001895 Giovanni Fabbrini [Italie] ; Piero Barbanti [Italie] ; Cinzia Aurilia [Italie] ; Nicola Vanacore [Italie] ; Caterina Pauletti [Italie] ; Giuseppe Meco [Italie]Excessive daytime sleepiness in de novo and treated Parkinson's disease
001897 Giovanni Defazio [Italie] ; Paolo Livrea [Italie]Epidemiology of primary blepharospasm
001902 Olivia Leoni [Italie] ; Emilia Martignoni [Italie] ; Marco Cosentino [Italie] ; Donatella Michielotto [Italie] ; Daniela Calandrella [Italie] ; Roberta Zangaglia [Italie] ; Giulio Riboldazzi [Italie] ; Cristina Oria [Italie] ; Sergio Lecchini [Italie] ; Giuseppe Nappi [Italie] ; Gianmario Frigo [Italie]Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients
001934 Pio Caso [Italie] ; Antonello D'Andrea [Italie] ; Carmine Musto [Italie] ; Stefano Nardi [Italie] ; Ciro Cavallaro [Italie] ; Alfonso Roberto Martiniello [Italie] ; Filippo Vecchione [Italie] ; Nicola Mininni [Italie] ; Raffaele Calabr [Italie] ; George R. Sutherland [Belgique]Assessment of Accessory Atrioventricular Pathways by Doppler Myocardial Imaging
001958 Davide Maimone [Italie] ; Roberto Dominici [Italie] ; Luigi M. E. Grimaldi [Italie]Pharmacogenomics of neurodegenerative diseases
001A34 Anna R. Bentivoglio [Italie] ; Pietro Cortelli [Italie] ; Enza M. Valente [Italie] ; Tàmara Ialongo [Italie] ; Alessandro Ferraris [Italie] ; Antonio Elia [Italie] ; Pasquale Montagna [Italie] ; Alberto Albanese [Italie]Phenotypic characterisation of autosomal recessive PARK6‐linked parkinsonism in three unrelated Italian families
001A45 Luc P. De Vreese [Italie] ; Mirco Neri [Italie] ; Mario Fioravanti [Italie] ; Luciano Belloi [Italie] ; Orazio Zanetti [Italie]Memory rehabilitation in Alzheimer's disease: a review of progress
001A48 Enza Maria Valente [Royaume-Uni] ; Anna Rita Bentivoglio [Italie] ; Peter H. Dixon [Royaume-Uni] ; Alessandro Ferraris [Italie] ; Tamara Ialongo [Italie] ; Marina Frontali [Italie] ; Alberto Albanese [Italie] ; Nicholas W. Wood [Royaume-Uni]Localization of a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, PARK6, on Human Chromosome 1p35-p36
001A50 T. Caraceni [Italie] ; M. Musicco [Italie]Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study
001A90 Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
001B34 Maria Agnes Sabatini [Italie] ; Gloria Innocenti [Italie]Functional relationships between Collembola and plant pathogenic fungi of agricultural soils
001B59 Silvana Tesei [Italie] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Anna Zecchinelli [Italie] ; Claudio B. Mariani [Italie] ; Gianni Pezzoli [Italie]Tolerability of paroxetine in Parkinson's disease: A prospective study
001B74 E. Farina [Italie] ; G. Gattellaro [Italie] ; S. Pomati [Italie] ; E. Magni [Italie] ; A. Perretti [Italie] ; A. P. Cannatà [Italie] ; P. Nichelli [Italie] ; C. Mariani [Italie]Researching a differential impairment of frontal functions and explicit memory in early Parkinson’s disease
001B91 Christine Klein [États-Unis, Allemagne] ; Peter P. Pramstaller [Italie] ; Bernhard Kis [Allemagne, Italie] ; Curtis C. Page [États-Unis] ; Martin Kann [États-Unis] ; Joanne Leung [États-Unis] ; Heather Woodward [États-Unis] ; Claudio C. Castellan [Italie] ; Monika Scherer [Italie] ; Peter Vieregge [Allemagne] ; Xandra O. Breakefield [États-Unis] ; Patricia L. Kramer [États-Unis] ; Laurie J. Ozelius [États-Unis]Parkin deletions in a family with adult‐onset, tremor‐dominant parkinsonism: Expanding the phenotype
001C15 Silvio Aime [Italie] ; Bruno Bergamasco [Italie] ; Mariano Casu [Italie] ; Giuseppe Digilio [Italie] ; Mauro Fasano [Italie] ; Sabrina Giraudo [Italie] ; Leonardo Lopiano [Italie]Isolation and 13C‐NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with parkinson's disease
001C23 Ulrich Finckh [Allemagne] ; Tomas Müller-Thomsen [Allemagne] ; Ulrike Mann [Allemagne] ; Christian Eggers [Allemagne] ; Josef Marksteiner [Autriche] ; Wolfgang Meins [Allemagne] ; Giuliano Binetti [Italie] ; Antonella Alberici [Italie] ; Christoph Hock ; Roger M. Nitsch [Suisse] ; Andreas Gal [Allemagne]High Prevalence of Pathogenic Mutations in Patients with Early-Onset Dementia Detected by Sequence Analyses of Four Different Genes
001C37 A. P Strafella [Italie] ; F. Valzania [Italie] ; S. A Nassetti [Italie] ; A. Tropeani [Italie] ; A. Bisulli [Italie] ; M. Santangelo [Italie] ; C. A Tassinari [Italie]Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study
001C44 Teodoro Del Ser [Espagne] ; Ian Mckeith [Royaume-Uni] ; Ravi Anand [États-Unis] ; Ana Cicin-Sain [Suisse] ; Roberto Ferrara [Italie] ; René Spiegel [Suisse]Dementia with Lewy bodies: findings from an international multicentre study
001C46 Massimo Valoti [Italie] ; Fabio Fusi [Italie] ; Maria Frosini [Italie] ; Federica Pessina [Italie] ; Keith F. Tipton [Irlande (pays)] ; Gian P. Sgaragli [Italie]Cytochrome P450-dependent n-dealkylation of l-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, β-naphthoflavone and l-deprenyl
001D22 U. Bonuccelli [Italie] ; C. D'Avino [Italie] ; N. Caraccio [Italie] ; P. Del Guerra [Italie] ; A. Casolaro [Italie] ; N. Pavese [Italie] ; P. Del Dotto [Italie] ; F. Monzani [Italie]Thyroid function and autoimmunity in Parkinson's disease: a study of 101 patients
001D74 Gambassi [Italie, États-Unis] ; Landi [Italie] ; Lapane [États-Unis] ; Sgadari [Italie] ; Mor [États-Unis] ; Bernabei [Italie]Is Drug Use by the Elderly with Cognitive Impairment Influenced by Type of Dementia?
001D78 Piero Barbanti ; Giovanni Fabbrini ; Alberto Ricci ; Rosanna Cerbo ; Elena Bronzetti ; Brunella Caronti ; Caterina Calderaro ; Laura Felici ; Fabrizio Stocchi [Italie] ; Giuseppe Meco ; Francesco Amenta [Italie] ; Gian Luigi LenziIncreased expression of dopamine receptors on lymphocytes in Parkinson's disease
001E12 L. Battistin [Italie] ; P. G. Bardin [Italie] ; F. Ferro-Milone ; C. Ravenna ; V. Toso [Italie] ; G. ReboldiAlpha‐dihydroergocryptine in Parkinson's disease: a multiceuntre randomized double blind parallel group study
001E40 P. Stanzione [Italie] ; R. Semprini [Italie] ; M. Pierantozzi [Italie] ; A. M Santilli [Italie] ; L. Fadda [Italie] ; R. Traversa [Italie] ; A. Peppe [Italie] ; G. Bernardi [Italie]Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy
001E63 Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie]Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study
001E74 R. Raschetti [Italie] ; S. Spila-Alegiani [Italie] ; N. Vanacore [Italie] ; C. Ancona [Italie] ; G. Meco [Italie]Mortality in a population‐based cohort of patients treated with antiparkinsonian drugs
001E83 L. Manfredi [Italie] ; P. Garavaglia [Italie] ; S. Beretta [Italie] ; G. Pellegrini [Italie]Increased cortical inhibition induced by apomorphine in patients with Parkinson's disease
001E87 Federico A. Dajas-Bailador [Uruguay, Royaume-Uni] ; Anibal Martinez-Borges [Uruguay] ; Gustavo Costa [Uruguay] ; J. Andrés Abin [Uruguay] ; Emilia Martignoni [Italie] ; Giuseppe Nappi [Italie] ; Federico Dajas [Uruguay]Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation
001F21 Johann Tassin ; Alexandra Dürr ; Thomas De Broucker [France] ; Nacer Abbas ; Vincenzo Bonifati ; Giuseppe De Michele ; Anne-Marie Bonnet ; Emmanuel Broussolle ; Pierre Pollak [France] ; Marie Vidailhet ; Michele De Mari ; Roberto Marconi [Italie] ; Soraya Medjbeur ; Allessandro Filla ; Giuseppe Meco ; Yves Agid [France] ; Alexis Brice [France]Chromosome 6–Linked Autosomal Recessive Early-Onset Parkinsonism: Linkage in European and Algerian Families, Extension of the Clinical Spectrum, and Evidence of a Small Homozygous Deletion in One Family
001F49 P. Faglioni [Italie] ; C. Botti [Italie] ; M. Scarpa [Italie] ; V. Ferrari [Italie] ; M. C Saetti [Italie]Learning and forgetting processes in Parkinson's disease:
001F90 Viktor Müller [Allemagne] ; Mohr [Allemagne] ; Regina Rosin [Allemagne] ; Friedemann Pulvermüller [Allemagne] ; Friedemann Müller [Allemagne] ; Niels Birbaumer [Allemagne, Italie]Short‐term effects of behavioral treatment on movement initiation and postural control in Parkinson's disease: A controlled clinical study
001F94 P. Stanzione [Italie] ; R. Traversa [Italie] ; M. Pierantozzi [Italie] ; R. Semprini [Italie] ; M. Loberti [Italie] ; A. Peppe [Italie] ; A. M. Santilli [Italie] ; G. Bernardi [Italie]SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status
002015 Mario Zappia ; Rosanna Colao ; Rita Montesanti ; Milena Rizzo ; Umberto Aguglia ; Antonio Gambardella ; Rosario L No Oliveri ; Aldo Quattrone [Italie]Long‐duration response to levodopa influences the pharmacodynamics of short‐duration response in Parkinson's disease
002096 Valentino Ducceschi [Italie] ; Berardo Sarubbi [Italie] ; Nicola Briglia [Italie] ; Lucio Santangelo [Italie] ; Aldo Iacono [Italie]Increased dispersion of ventricular recovery time as a new repolarization abnormality in the Wolff-Parkinson-White syndrome
002151 F. Tison [France] ; K. Wenning [Autriche] ; A. Volonte [Italie] ; R. Poewe [Autriche] ; P. Henry [France] ; P. Quinn [Royaume-Uni]Pain in multiple system atrophy
002171 Ma Rosario De La Torre [Espagne] ; Angela Casado [Espagne] ; Encarnaci N L Pez-Fernández [Espagne] ; Diana Carrascosa [Espagne] ; Concepci N Casado [Espagne] ; Domenico Venarucci [Italie] ; Vincenzo Venarucci [Italie]Human aging brain disorders: Role of antioxidant enzymes
002179 G. De Michele ; A. Filla ; G. Volpe ; V. De Marco ; A. Gogliettino ; G. Ambrosio ; R. Marconi [Italie] ; A. E. Castellano [Italie] ; CampanellaEnvironmental and genetic risk factors in Parkinson's disease: A case–control study in southern italy
002191 Giancarlo Logroscino [États-Unis, Italie] ; Karen Marder [États-Unis] ; Lucien Cote [États-Unis] ; Ming-Xin Tang [États-Unis] ; Steven Shea [États-Unis] ; Mayeux [États-Unis]Dietary lipids and antioxidants in Parkinson's disease: A population‐based, case‐control study
002196 M. Battino ; P. Littarru ; A. Gorini [Italie] ; F. Villa [Italie]Coenzyme Q, peroxidation and cytochrome oxidase features after Parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca Fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine
002197 Golbe [États-Unis] ; Alice M. Lazzarini [États-Unis] ; Roger C. Duvoisin [États-Unis] ; Giuseppe Di Iorio [Italie] ; Giuseppe Sanges [Italie] ; Vincenzo Bonavita [Italie] ; Salvatore La Sala [Italie]Clinical genetic analysis of Parkinson's disease in the contursi kindred
002202 Geminiani [Italie] ; Vincenza Fetoni [Italie] ; Silvia Genitrini [Italie] ; Paolo Giovannini [Italie] ; Filippo Tamma [Italie] ; Tommaso Caraceni [Italie]Cabergoline in Parkinson's disease complicated by motor fluctuations
002214 Pietro Galvani [Italie] ; Pietro Fumagalli [Italie] ; Angela Santagostino [Italie]Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese
002239 Paolo M. Rossini [Italie] ; M. Antonietta Bassetti [Italie] ; Patrizio Pasqualetti [Italie]Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components Clin. Parkinson's disease and in parkinsonism
002254 D. D'Este [Italie] ; A. Pasqual [Italie] ; M. Bertaglia [Italie] ; M. P. Meneghello [Italie] ; A. Zanocco [Italie] ; P. Delise ; F. D'Este [Italie] ; P. Pascotto [Italie]Evaluation of atrial vulnerability with transoesophageal stimulation in patients with atrioventricular junctional
002259 Cristina Basso [Italie] ; Carla Frescura [Italie] ; Domenico Corrado [Italie] ; Michela Muriago [Italie] ; Annalisa Angelini [Italie] ; Luciano Daliento [Italie] ; Gaetano Thiene [Italie]Congenital heart disease and sudden death in the young
002262 O. Pastoris [Italie] ; M. Dossena [Italie] ; P. Foppa [Italie] ; M. Catapano [Italie] ; R. Ferrari [Italie] ; F. Dagani [Italie]Biochemical evaluations in skeletal muscles of primates with MPTP parkinson-like syndrome
002305 G. Finali [Italie] ; M. Piccirilli [Italie] ; S. Rizzuto [Italie]Neuropsychological characteristics of parkinsonian patients with lateralized motor impairment
002349 Annibale Sandro Montenero [Italie] ; Filippo Crea [Italie] ; Maria Grazia Bendini [Italie] ; Fulvio Bellocci [Italie] ; Paolo Zecchi [Italie]Catheter Ablation of Left Accessory Atrioventricular Connections: The Transseptal Approach
002370 Giuseppe Biagini [Italie] ; Andrea Frasoldati [Italie] ; Kjell Fuxe [Suède] ; Luigi F. Agnati [Italie]The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: Evidence for l-deprenyl-induced activation of reactive astrocytes
002380 Umberto Castiello [Italie] ; Keree M. B. Bennett [Italie]Parkinson's disease: reorganization of the reach to grasp movement in response to perturbation of the distal motor patterning
002382 A. Priori [Italie] ; A. Berardelli [Italie] ; M. Inghilleri [Italie] ; N. Accornero [Italie] ; M. Manfredi [Italie]Motor cortical inhibition and the dopaminergic system
002396 Mario Zappia [Italie] ; Rita Montesanti [Italie] ; Rosanna Colao [Italie] ; Aldo Quattrone [Italie]Usefulness of movement time in the assessment of Parkinson's disease
002400 S. Enochs [États-Unis] ; T. Sarna [Pologne] ; L. Zecca [Italie] ; A. Riley [Royaume-Uni] ; M. Swartz [États-Unis]The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: A hypothesis
002409 V. Govoni [Italie] ; E. Granieri [Italie] ; M. R. Tola [Italie] ; I. Casetta [Italie] ; V. C. Monetti [Italie] ; E. Fainardi [Italie] ; E. Paolino [Italie]Prevalence of anti‐parkinson drugs’ use in Ferrara, Northern Italy, 1988
002414 Scarpa [Italie] ; Umberto Castiello [Italie]Perturbation of a prehension movement in Parkinson's disease
002415 F. Villa [Italie] ; R. Arnaboldi [Italie] ; B. Ghigini [Italie] ; A. Gorini [Italie]Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca Fascicularis : Synaptosomal metabolism and action of dihydroergocriptine
002428 Roberto Marconi [France, Italie] ; Dominique Lefebvre-Caparros [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Bruno Dubois [France] ; Agid [France]Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
002439 E. Farina ; S. F. Cappa [Italie] ; M. Polimeni ; E. Magni [Italie] ; M. Canesi ; A. Zecchinelli ; G. Scarlato ; C. MarianiFrontal dysfunction in early Parkinson's diseases
002454 Letizia Mazzini [Italie] ; Daniela Testa [Italie] ; Carla Balzarini [Italie] ; Gabriele Mora [Italie]An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis
002470 Umberto Castiello [Italie] ; George E. Stelmach [États-Unis] ; Abraham N. Lieberman [États-Unis]Temporal dissociation of the prehension pattern in Parkinson's disease
002477 Giancarlo Finali ; Massimo Piccirilli ; Gian Luigi Piccinin [Italie]Neuropsychological correlates of l-deprenyl therapy in idiopathic parkinsonism
002510 Angelo Graffigna [Italie] ; Francesco Pagani [Italie] ; Mario Vigano [Italie]Surgical Treatment of Wolff‐Parkinson‐White Syndrome: Epicardial Approach Without the Use of Cardiopulmonary Bypass
002529 G. Bernocchi [Italie] ; G. Gerzeli [Italie] ; E. Scherini [Italie] ; C. Vignola [Italie]Neuroprotective effects of α-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,3,3,6-tetrahydropyridine
002537 R. Volpi [Italie] ; P. Caffarra [Italie] ; A. Scaglioni [Italie] ; A. Saginario [Italie] ; D. Maestri [Italie] ; S. Vourna [Italie] ; P. Vescovi [Italie] ; P. Chiodera [Italie] ; V. Coiro [Italie]Lack of ACTH/cortisol and GH responses to intravenously-infused substance P in Parkinson's disease
002546 Fulvio Marzatico [Italie] ; Carla Café [Italie] ; Monica Taborelli [Italie] ; Gianni Benzi [Italie]Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas
002548 Milena De Marinis [Italie] ; Guido Argenta [Italie] ; Domenico Mele [Italie] ; Antonio Carbone [Italie] ; Giulio Baffigo [Italie] ; Alessandro Agnoli [Italie]Evaluation of vesico-urethral and sweating function in disorders presenting with parkinsonism
002559 R. Musanti [Italie] ; E. Parati [Italie] ; E. Lamperti [Italie] ; G. Ghiselli [Italie]Decreased Cholesterol Biosynthesis in Fibroblasts from Patients with Parkinson Disease
002564 Giovanni Diana [Italie] ; Stefania Spila Alegiani [Italie] ; Marco Fortini [Italie] ; Roberto [Italie] ; Roberto Raschetti [Italie]Anticholinergic anti‐Parkinson drug prescription in haloperidol‐treated patients: A population‐based study
002570 G. Vignati [Italie] ; L. Mauri [Italie] ; M. Lunati [Italie] ; M. Gasparini [Italie] ; A. Figini [Italie]Transoesophageal electrophysiological evaluation of paediatric patients with Wolff-Parkinson-White syndrome
002627 G. Chinaglia [Suisse, Italie] ; F. J. Alvarez [Espagne] ; A. Probst [Suisse] ; J. M. Palacios [Espagne]Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: A quantitative autoradiographic study using [3H]mazindol
002633 L. Angelini [Italie] ; N. Nardocci [Italie] ; V. Rumi [Italie] ; C. Zorzi [Italie] ; L. Strada [Italie] ; M. Savoiardo [Italie]Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life
002656 Stefano Favale [Italie] ; Francesco Minafra [Italie] ; Vincenzo Massari [Italie] ; Massimo Tritto [Italie] ; Paolo Rizzon [Italie]Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome
002674 Patrizia Ferrero [Italie] ; Paola Rocca [Italie] ; Carola Eva [Italie] ; Paolo Benna [Italie] ; Nicoletta Rebaudengo [Italie] ; Luigi Ravizza [Italie] ; Enrico Genazzani [Italie] ; Bruno Bergamasco [Italie]AN ANALYSIS OF LYMPHOCYTE3H-N-METHYL-SCOPOLAMINE BINDING IN NEUROLOGICAL PATIENTS
002679 Roberto Bolognesi [Italie]The pharmacologic treatment of atrial fibrillation
002681 G. Benzi [Italie] ; D. Curti [Italie] ; O. Pastoris [Italie] ; F. Marzatico [Italie] ; F. Villa [Italie] ; F. Dagani [Italie]Sequential damage in mitochondrial complexes by peroxidative stress
002688 G. Bellomo [Italie] ; L. Santambrogio [Italie] ; M. Fiacconi [Italie] ; M. Scarponi [Italie] ; G. Ciuffetti [Italie]Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated parkinson's disease
002701 G. Cusimano [Italie] ; C. Capriani [Italie] ; V. Bonifati [Italie] ; G. Meco [Italie]Hypothalamo‐pituitary function and dopamine dependence in untreated parkinsonian patients
002713 R. Fenici [Italie] ; Guido Melillo [Italie] ; Mariella Masselli [Italie]Clinical magnetocardiography
002717 Giuseppe Meco [Italie] ; Luca Pratesi [Italie] ; Vincenzo Bonifati [Italie]Cardiovascular reflexes and autonomic dysfunction in parkinson's disease
002747 J. Zayed [Italie] ; P. André [Italie] ; C. Panisset [Italie] ; S. Ducic [Italie] ; G. Campanella [Italie] ; M. Roy [Italie] ; G. Kennedy [Italie] ; C. Delisle [Italie]Contamination environnementale par les métaux et maladie de Parkinson
002769 B. Bergamasco [Italie] ; P. Benna [Italie] ; L. Scarzella [Italie]Long‐term bromocriptine treatment of de novo patients with Parkinson's disease. A seven‐year follow‐up
002786 M. Camerlingo [Italie] ; B. Ferraro [Italie] ; G. C. Gazzaniga [Italie] ; L. Casto [Italie] ; B. M. Cesana [Italie] ; A. Mamoli [Italie]Cardiovascular reflexes in Parkinson's disease: long‐term effects of levodopa treatment on de novo patients
002790 Lawrence I. Golbe [États-Unis] ; Giuseppe Di Iorio [Italie] ; Vincenzo Bonavita [Italie] ; Douglas C. Miller [États-Unis] ; Roger C. Duvoisin [États-Unis]A large kindred with autosomal dominant Parkinson's disease
002859 G. Vergara [Italie] ; F. Furlanello [Italie] ; M. Disertori [Italie] ; G. Inama [Italie] ; M. Guarnerio [Italie] ; R. Bettini [Italie] ; F. Cozzi [Italie]Induction of supraventricular tachyarrhythmia at rest and during exercise with transoesophageal atrial pacing in the electrophysiological evaluation of asymptomatic athletes with Wolff-Parkinson-White Syndrome
002865 A. Michei [Italie] ; L. Padeletti [Italie] ; D. Monizzi [Italie] ; M. C. Porciani [Italie] ; R. Musante [Italie] ; V. Cupelli [Italie] ; P. Delise [Italie] ; D. D'Este [Italie]Atrial electrophysiologic properties of patients with asymptomatic Wolff-Parkinson-White syndrome
002873 M. M. Mouradian [États-Unis] ; J. L. Junecos [États-Unis] ; G. Fabbrini [États-Unis, Italie] ; J. Schlegel [États-Unis] ; J. J. Bartko [États-Unis] ; Chase [États-Unis]Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II
002874 G. Fabbnni [États-Unis, Italie] ; M. M. Mouradian [États-Unis] ; J. L. Junecos [États-Unis] ; J. Schlegel [États-Unis] ; E. Mohr [États-Unis] ; Chase [États-Unis]Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part I
002884 L. Cipparrone [Italie] ; A. Ginanneschi [Italie] ; F. Degl'Innocenti [Italie] ; P. Porzio [Italie] ; P. Pagnini [Italie] ; P. Marini M. D [Italie]Electro‐oculographic routine examination in Parkinson's disease
002905 K. C. Mccullough [Royaume-Uni, Suisse] ; J. R. Crowther [Royaume-Uni] ; W. C. Carpenter [Royaume-Uni] ; E. Brocchi [Italie] ; L. Capucci [Italie] ; F. De Simone [Italie] ; Q. Xie [Royaume-Uni] ; D. Mccahon [Royaume-Uni]Epitopes on foot-and-mouth disease virus particles I. Topology
002944 Michele Brignole [Italie] ; Carlo Menozzi [Italie] ; Bruno Sartore [Italie] ; Mauro Barra [Italie] ; Igor Monducci [Italie]The use of atrial pacing to induce atrial fibrillation and flutter
002996 P. Alboni [Italie] ; N. Paparella [Italie] ; R. Pirani [Italie] ; R. Cappato [Italie] ; A. M. Cuccí [Italie] ; E. Ruffilli [Italie] ; A. M. Tomasi [Italie]Different electrophysiological modes of action of oral quinidine in man
002A83 F. Tagliavini [Suisse] ; G. Pilleri [Suisse] ; F. Gemignani [Italie] ; A. Lechi [Italie]Neuronal loss in the basal nucleus of meynert in progressive supranuclear palsy
002B06 Lodovico Frattola [Italie] ; Maria Grazia Albizzati [Italie] ; Sirio Bassi [Italie] ; Carlo Ferrarese [Italie] ; Marco Trabucchi [Italie]“On‐off” phenomena, dyskinesias and dystonias
002B17 Claudio Villardita [Italie] ; Pietro Smirni [Italie] ; Francesco Le Pira [Italie] ; Giuseppe Zappala [Italie] ; Francesco Nicoleiti [Italie]Mental deterioration, visuoperceptive disabilities and constructional apraxia in Parkinson's disease
002B47 A. Agnoli [Italie] ; M. Baldassarre [Italie] ; S. Ruggieri [Italie] ; P. Falaschi [Italie] ; D. Urso [Italie] ; A. Rocco [Italie]Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response
002B71 G. Rosati [Italie] ; P. De Bastiani [Italie] ; P. Gilli [Italie] ; E. Paolino [Italie]Oral aluminum and neuropsychological functioning
002C04 Leontino Battistin [Italie] ; Giorgio Meneghetti [Italie] ; Simone Rigotti [Italie] ; Aldo Saia [Italie]Long‐term treatment of Parkinson's disease with L‐Dopa and Dopa‐decarboxylase inhibitor: Therapeutic results and side effects
002C21 Rosati [Italie] ; L. Pinna [Italie] ; E. Granieri [Italie] ; I. Aiello [Italie] ; R. Tola [Italie] ; V. Agnetti [Italie] ; A. Pirisi [Italie] ; P. De Bastiani [Italie]STUDIES ON EPIDEMIOLOGICAL, CLINICAL AND ETIOLOGICAL ASPECTS OF ALS DISEASE IN SARDINIA, SOUTHERN ITALY
002C32 G. Campanella [Italie] ; S. Algeri [Italie] ; C. Cerletti [Italie] ; E. Dolfini [Italie] ; A. Jori [Italie] ; F. Rinaldi [Italie]Correlation of clinical symptoms, HVA and 5-HIAA in CSF and plasma L-DOPA in parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024